{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:44:20Z","timestamp":1790693060822,"version":"4.1.0"},"reference-count":214,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,11,18]],"date-time":"2017-11-18T00:00:00Z","timestamp":1510963200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,11,18]],"date-time":"2017-11-18T00:00:00Z","timestamp":1510963200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R21-NS099757"],"award-info":[{"award-number":["R21-NS099757"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["P50NS072187"],"award-info":[{"award-number":["P50NS072187"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1007\/s00401-017-1788-5","type":"journal-article","created":{"date-parts":[[2017,11,18]],"date-time":"2017-11-18T12:51:13Z","timestamp":1511009473000},"page":"13-32","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":105,"title":["Parkinson\u2019s disease: experimental models and reality"],"prefix":"10.1007","volume":"135","author":[{"given":"Peizhou","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7189-7917","authenticated-orcid":false,"given":"Dennis W.","family":"Dickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,18]]},"reference":[{"key":"1788_CR1","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1056\/NEJMoa033277","volume":"351","author":"J Aharon-Peretz","year":"2004","unstructured":"Aharon-Peretz J, Rosenbaum H, Gershoni-Baruch R (2004) Mutations in the glucocerebrosidase gene and Parkinson\u2019s disease in Ashkenazi Jews. New Engl J Med 351:1972\u20131977. https:\/\/doi.org\/10.1056\/Nejmoa033277","journal-title":"New Engl J Med"},{"key":"1788_CR2","doi-asserted-by":"publisher","first-page":"16503","DOI":"10.1523\/JNEUROSCI.0209-12.2012","volume":"32","author":"I Ahmed","year":"2012","unstructured":"Ahmed I, Liang Y, Schools S, Dawson VL, Dawson TM, Savitt JM (2012) Development and characterization of a new Parkinson\u2019s disease model resulting from impaired autophagy. J Neurosci 32:16503\u201316509. https:\/\/doi.org\/10.1523\/JNEUROSCI.0209-12.2012","journal-title":"J Neurosci"},{"key":"1788_CR3","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s00401-009-0523-2","volume":"117","author":"I Alafuzoff","year":"2009","unstructured":"Alafuzoff I, Ince PG, Arzberger T, Al-Sarraj S, Bell J, Bodi I, Bogdanovic N, Bugiani O, Ferrer I, Gelpi E, Gentleman S, Giaccone G, Ironside JW, Kavantzas N, King A, Korkolopoulou P, Kovacs GG, Meyronet D, Monoranu C, Parchi P, Parkkinen L, Patsouris E, Roggendorf W, Rozemuller A, Stadelmann-Nessler C, Streichenberger N, Thal DR, Kretzschmar H (2009) Staging\/typing of Lewy body related alpha-synuclein pathology: a study of the BrainNet Europe Consortium. Acta Neuropathol 117:635\u2013652. https:\/\/doi.org\/10.1007\/s00401-009-0523-2","journal-title":"Acta Neuropathol"},{"key":"1788_CR4","doi-asserted-by":"publisher","first-page":"14807","DOI":"10.1073\/pnas.0703219104","volume":"104","author":"E Andres-Mateos","year":"2007","unstructured":"Andres-Mateos E, Perier C, Zhang L, Blanchard-Fillion B, Greco TM, Thomas B, Ko HS, Sasaki M, Ischiropoulos H, Przedborski S, Dawson TM, Dawson VL (2007) DJ-1 gene deletion reveals that DJ-1 is an atypical peroxiredoxin-like peroxidase. Proc Natl Acad Sci USA 104:14807\u201314812. https:\/\/doi.org\/10.1073\/pnas.0703219104","journal-title":"Proc Natl Acad Sci USA"},{"key":"1788_CR5","first-page":"25","volume":"12","author":"P Anglade","year":"1997","unstructured":"Anglade P, Vyas S, JavoyAgid F, Herrero MT, Michel PP, Marquez J, MouattPrigent A, Ruberg M, Hirsch EC, Agid Y (1997) Apoptosis and autophagy in nigral neurons of patients with Parkinson\u2019s disease. Histol Histopathol 12:25\u201331","journal-title":"Histol Histopathol"},{"key":"1788_CR6","doi-asserted-by":"publisher","first-page":"683920","DOI":"10.1155\/2013\/683920","volume":"2013","author":"H Ariga","year":"2013","unstructured":"Ariga H, Takahashi-Niki K, Kato I, Maita H, Niki T, Iguchi-Ariga SM (2013) Neuroprotective function of DJ-1 in Parkinson\u2019s disease. Oxid Med Cell Longev 2013:683920. https:\/\/doi.org\/10.1155\/2013\/683920","journal-title":"Oxid Med Cell Longev"},{"key":"1788_CR7","doi-asserted-by":"publisher","first-page":"2750","DOI":"10.1093\/brain\/aws193","volume":"135","author":"C Baiguera","year":"2012","unstructured":"Baiguera C, Alghisi M, Pinna A, Bellucci A, De Luca MA, Frau L, Morelli M, Ingrassia R, Benarese M, Porrini V, Pellitteri M, Bertini G, Fabene PF, Sigala S, Spillantini MG, Liou HC, Spano PF, Pizzi M (2012) Late-onset Parkinsonism in NFkappaB\/c-Rel-deficient mice. Brain 135:2750\u20132765. https:\/\/doi.org\/10.1093\/brain\/aws193","journal-title":"Brain"},{"key":"1788_CR8","doi-asserted-by":"publisher","first-page":"16188","DOI":"10.1074\/jbc.274.23.16188","volume":"274","author":"A Barrientos","year":"1999","unstructured":"Barrientos A, Moraes CT (1999) Titrating the effects of mitochondrial complex I impairment in the cell physiology. J Biol Chem 274:16188\u201316197. https:\/\/doi.org\/10.1074\/jbc.274.23.16188","journal-title":"J Biol Chem"},{"key":"1788_CR9","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s00401-009-0538-8","volume":"117","author":"TG Beach","year":"2009","unstructured":"Beach TG, Adler CH, Lue L, Sue LI, Bachalakuri J, Henry-Watson J, Sasse J, Boyer S, Shirohi S, Brooks R, Eschbacher J, White CL 3rd, Akiyama H, Caviness J, Shill HA, Connor DJ, Sabbagh MN, Walker DG (2009) Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction. Acta Neuropathol 117:613\u2013634. https:\/\/doi.org\/10.1007\/s00401-009-0538-8","journal-title":"Acta Neuropathol"},{"key":"1788_CR10","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3233\/JPD-150680","volume":"6","author":"TG Beach","year":"2016","unstructured":"Beach TG, Adler CH, Serrano G, Sue LI, Walker DG, Dugger BN, Shill HA, Driver-Dunckley E, Caviness JN, Intorcia A, Filon J, Scott S, Garcia A, Hoffman B, Belden CM, Davis KJ, Sabbagh MN (2016) Prevalence of submandibular gland synucleinopathy in Parkinson\u2019s disease, dementia with Lewy bodies and other Lewy body disorders. J Parkinsons Dis 6:153\u2013163. https:\/\/doi.org\/10.3233\/JPD-150680","journal-title":"J Parkinsons Dis"},{"key":"1788_CR11","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s00401-010-0664-3","volume":"119","author":"TG Beach","year":"2010","unstructured":"Beach TG, Adler CH, Sue LI, Vedders L, Lue L, White Iii CL, Akiyama H, Caviness JN, Shill HA, Sabbagh MN, Walker DG (2010) Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders. Acta Neuropathol 119:689\u2013702. https:\/\/doi.org\/10.1007\/s00401-010-0664-3","journal-title":"Acta Neuropathol"},{"key":"1788_CR12","doi-asserted-by":"publisher","first-page":"8189","DOI":"10.1523\/JNEUROSCI.2218-08.2008","volume":"28","author":"L Bedford","year":"2008","unstructured":"Bedford L, Hay D, Devoy A, Paine S, Powe DG, Seth R, Gray T, Topham I, Fone K, Rezvani N, Mee M, Soane T, Layfield R, Sheppard PW, Ebendal T, Usoskin D, Lowe J, Mayer RJ (2008) Depletion of 26S proteasomes in mouse brain neurons causes neurodegeneration and Lewy-like inclusions resembling human pale bodies. J Neurosci 28:8189\u20138198. https:\/\/doi.org\/10.1523\/JNEUROSCI.2218-08.2008","journal-title":"J Neurosci"},{"key":"1788_CR13","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1212\/WNL.0000000000001332","volume":"84","author":"GW Beecham","year":"2015","unstructured":"Beecham GW, Dickson DW, Scott WK, Martin ER, Schellenberg G, Nuytemans K, Larson EB, Buxbaum JD, Trojanowski JQ, Van Deerlin VM, Hurtig HI, Mash DC, Beach TG, Troncoso JC, Pletnikova O, Frosch MP, Ghetti B, Foroud TM, Honig LS, Marder K, Vonsattel JP, Goldman SM, Vinters HV, Ross OA, Wszolek ZK, Wang L, Dykxhoorn DM, Pericak-Vance MA, Montine TJ, Leverenz JB, Dawson TM, Vance JM (2015) PARK10 is a major locus for sporadic neuropathologically confirmed Parkinson disease. Neurology 84:972\u2013980. https:\/\/doi.org\/10.1212\/WNL.0000000000001332","journal-title":"Neurology"},{"key":"1788_CR14","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1093\/hmg\/ddr502","volume":"21","author":"C Belal","year":"2012","unstructured":"Belal C, Ameli NJ, El Kommos A, Bezalel S, Al\u2019Khafaji AM, Mughal MR, Mattson MP, Kyriazis GA, Tyrberg B, Chan SL (2012) The homocysteine-inducible endoplasmic reticulum (ER) stress protein Herp counteracts mutant alpha-synuclein-induced ER stress via the homeostatic regulation of ER-resident calcium release channel proteins. Hum Mol Genet 21:963\u2013977. https:\/\/doi.org\/10.1093\/hmg\/ddr502","journal-title":"Hum Mol Genet"},{"key":"1788_CR15","doi-asserted-by":"publisher","first-page":"33855","DOI":"10.1074\/jbc.274.48.33855","volume":"274","author":"MC Bennett","year":"1999","unstructured":"Bennett MC, Bishop JF, Leng Y, Chock PB, Chase TN, Mouradian MM (1999) Degradation of alpha-synuclein by proteasome. J Biol Chem 274:33855\u201333858","journal-title":"J Biol Chem"},{"key":"1788_CR16","doi-asserted-by":"publisher","first-page":"68","DOI":"10.3389\/fnbeh.2015.00068","volume":"9","author":"E Bentea","year":"2015","unstructured":"Bentea E, Van der Perren A, Van Liefferinge J, El Arfani A, Albertini G, Demuyser T, Merckx E, Michotte Y, Smolders I, Baekelandt V, Massie A (2015) Nigral proteasome inhibition in mice leads to motor and non-motor deficits and increased expression of Ser129 phosphorylated alpha-synuclein. Front Behav Neurosci 9:68. https:\/\/doi.org\/10.3389\/fnbeh.2015.00068","journal-title":"Front Behav Neurosci"},{"key":"1788_CR17","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.neuint.2016.10.001","volume":"101","author":"N Bhattacharjee","year":"2016","unstructured":"Bhattacharjee N, Borah A (2016) Oxidative stress and mitochondrial dysfunction are the underlying events of dopaminergic neurodegeneration in homocysteine rat model of Parkinson\u2019s disease. Neurochem Int 101:48\u201355. https:\/\/doi.org\/10.1016\/j.neuint.2016.10.001","journal-title":"Neurochem Int"},{"issue":"Suppl 2","key":"1788_CR18","doi-asserted-by":"publisher","first-page":"S124","DOI":"10.1016\/j.parkreldis.2008.04.015","volume":"14","author":"F Blandini","year":"2008","unstructured":"Blandini F, Armentero MT, Martignoni E (2008) The 6-hydroxydopamine model: news from the past. Parkinsonism Relat Disord 14(Suppl 2):S124\u2013S129. https:\/\/doi.org\/10.1016\/j.parkreldis.2008.04.015","journal-title":"Parkinsonism Relat Disord"},{"key":"1788_CR19","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1126\/science.1077209","volume":"299","author":"V Bonifati","year":"2003","unstructured":"Bonifati V, Rizzu P, van Baren MJ, Schaap O, Breedveld GJ, Krieger E, Dekker MC, Squitieri F, Ibanez P, Joosse M, van Dongen JW, Vanacore N, van Swieten JC, Brice A, Meco G, van Duijn CM, Oostra BA, Heutink P (2003) Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 299:256\u2013259. https:\/\/doi.org\/10.1126\/science.1077209","journal-title":"Science"},{"key":"1788_CR20","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1002\/ana.20937","volume":"60","author":"J Bove","year":"2006","unstructured":"Bove J, Zhou C, Jackson-Lewis V, Taylor J, Chu Y, Rideout HJ, Wu DC, Kordower JH, Petrucelli L, Przedborski S (2006) Proteasome inhibition and Parkinson\u2019s disease modeling. Ann Neurol 60:260\u2013264. https:\/\/doi.org\/10.1002\/ana.20937","journal-title":"Ann Neurol"},{"key":"1788_CR21","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1002\/mds.21065","volume":"21","author":"H Braak","year":"2006","unstructured":"Braak H, Bohl JR, Muller CM, Rub U, de Vos RA, Del Tredici K (2006) Stanley Fahn Lecture 2005: the staging procedure for the inclusion body pathology associated with sporadic Parkinson\u2019s disease reconsidered. Mov Disord 21:2042\u20132051. https:\/\/doi.org\/10.1002\/mds.21065","journal-title":"Mov Disord"},{"key":"1788_CR22","doi-asserted-by":"publisher","first-page":"S73","DOI":"10.3233\/JPD-179001","volume":"7","author":"H Braak","year":"2017","unstructured":"Braak H, Del Tredici K (2017) Neuropathological staging of brain pathology in sporadic Parkinson\u2019s disease: separating the wheat from the chaff. J Parkinsons Dis 7:S73\u2013S87. https:\/\/doi.org\/10.3233\/JPD-179001","journal-title":"J Parkinsons Dis"},{"key":"1788_CR23","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging 24:197\u2013211","journal-title":"Neurobiol Aging"},{"key":"1788_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0006-8993(98)01192-5","volume":"823","author":"AI Brooks","year":"1999","unstructured":"Brooks AI, Chadwick CA, Gelbard HA, Cory-Slechta DA, Federoff HJ (1999) Paraquat elicited neurobehavioral syndrome caused by dopaminergic neuron loss. Brain Res 823:1\u201310","journal-title":"Brain Res"},{"key":"1788_CR25","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.brainres.2010.02.045","volume":"1326","author":"S Bukhatwa","year":"2010","unstructured":"Bukhatwa S, Zeng BY, Rose S, Jenner P (2010) A comparison of changes in proteasomal subunit expression in the substantia nigra in Parkinson\u2019s disease, multiple system atrophy and progressive supranuclear palsy. Brain Res 1326:174\u2013183. https:\/\/doi.org\/10.1016\/j.brainres.2010.02.045","journal-title":"Brain Res"},{"key":"1788_CR26","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddw353","author":"N Casadei","year":"2016","unstructured":"Casadei N, Sood P, Ulrich T, Fallier-Becker P, Kieper N, Helling S, May C, Glaab E, Chen J, Nuber S, Wolburg H, Marcus K, Rapaport D, Ott T, Riess O, Kruger R, Fitzgerald JC (2016) Mitochondrial defects and neurodegeneration in mice overexpressing wild-type or G399S mutant HtrA2. Hum Mol Genet. https:\/\/doi.org\/10.1093\/hmg\/ddw353","journal-title":"Hum Mol Genet"},{"key":"1788_CR27","first-page":"55","volume":"58","author":"DE Casey","year":"1997","unstructured":"Casey DE (1997) The relationship of pharmacology to side effects. J Clin Psychiatry 58:55\u201362","journal-title":"J Clin Psychiatry"},{"key":"1788_CR28","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1093\/hmg\/ddr048","volume":"20","author":"NC Chan","year":"2011","unstructured":"Chan NC, Salazar AM, Pham AH, Sweredoski MJ, Kolawa NJ, Graham RL, Hess S, Chan DC (2011) Broad activation of the ubiquitin-proteasome system by Parkin is critical for mitophagy. Hum Mol Genet 20:1726\u20131737. https:\/\/doi.org\/10.1093\/hmg\/ddr048","journal-title":"Hum Mol Genet"},{"key":"1788_CR29","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.nbd.2007.11.011","volume":"29","author":"JS Chandran","year":"2008","unstructured":"Chandran JS, Lin X, Zapata A, Hoke A, Shimoji M, Moore SO, Galloway MP, Laird FM, Wong PC, Price DL, Bailey KR, Crawley JN, Shippenberg T, Cai H (2008) Progressive behavioral deficits in DJ-1-deficient mice are associated with normal nigrostriatal function. Neurobiol Dis 29:505\u2013514. https:\/\/doi.org\/10.1016\/j.nbd.2007.11.011","journal-title":"Neurobiol Dis"},{"key":"1788_CR30","doi-asserted-by":"publisher","first-page":"21418","DOI":"10.1074\/jbc.M413955200","volume":"280","author":"L Chen","year":"2005","unstructured":"Chen L, Cagniard B, Mathews T, Jones S, Koh HC, Ding Y, Carvey PM, Ling Z, Kang UJ, Zhuang X (2005) Age-dependent motor deficits and dopaminergic dysfunction in DJ-1 null mice. J Biol Chem 280:21418\u201321426. https:\/\/doi.org\/10.1074\/jbc.M413955200","journal-title":"J Biol Chem"},{"key":"1788_CR31","doi-asserted-by":"publisher","first-page":"36027","DOI":"10.1074\/jbc.M304854200","volume":"278","author":"Q Chen","year":"2003","unstructured":"Chen Q, Vazquez EJ, Moghaddas S, Hoppel CL, Lesnefsky EJ (2003) Production of reactive oxygen species by mitochondria: central role of complex III. J Biol Chem 278:36027\u201336031. https:\/\/doi.org\/10.1074\/jbc.M304854200","journal-title":"J Biol Chem"},{"key":"1788_CR32","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s13311-012-0104-2","volume":"9","author":"MF Chesselet","year":"2012","unstructured":"Chesselet MF, Richter F, Zhu C, Magen I, Watson MB, Subramaniam SR (2012) A progressive mouse model of Parkinson\u2019s disease: the Thy1-aSyn (\u201cLine 61\u201d) mice. Neurotherapeutics 9:297\u2013314. https:\/\/doi.org\/10.1007\/s13311-012-0104-2","journal-title":"Neurotherapeutics"},{"key":"1788_CR33","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12896-016-0234-4","volume":"16","author":"VT Chu","year":"2016","unstructured":"Chu VT, Weber T, Graf R, Sommermann T, Petsch K, Sack U, Volchkov P, Rajewsky K, Kuhn R (2016) Efficient generation of Rosa26 knock-in mice using CRISPR\/Cas9 in C57BL\/6 zygotes. BMC Biotechnol 16:4. https:\/\/doi.org\/10.1186\/s12896-016-0234-4","journal-title":"BMC Biotechnol"},{"key":"1788_CR34","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.tips.2009.06.005","volume":"30","author":"F Cicchetti","year":"2009","unstructured":"Cicchetti F, Drouin-Ouellet J, Gross RE (2009) Environmental toxins and Parkinson\u2019s disease: what have we learned from pesticide-induced animal models? Trends Pharmacol Sci 30:475\u2013483. https:\/\/doi.org\/10.1016\/j.tips.2009.06.005","journal-title":"Trends Pharmacol Sci"},{"key":"1788_CR35","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.brainres.2004.07.026","volume":"1022","author":"KJ Conn","year":"2004","unstructured":"Conn KJ, Gao W, McKee A, Lan MS, Ullman MD, Eisenhauer PB, Fine RE, Wells JM (2004) Identification of the protein disulfide isomerase family member PDIp in experimental Parkinson\u2019s disease and Lewy body pathology. Brain Res 1022:164\u2013172. https:\/\/doi.org\/10.1016\/j.brainres.2004.07.026","journal-title":"Brain Res"},{"key":"1788_CR36","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-016-0114-x","author":"V Coppola-Segovia","year":"2016","unstructured":"Coppola-Segovia V, Cavarsan C, Maia FG, Ferraz AC, Nakao LS, Lima MM, Zanata SM (2016) ER stress induced by tunicamycin triggers alpha-synuclein oligomerization, dopaminergic neurons death and locomotor impairment: a new model of Parkinson\u2019s disease. Mol Neurobiol. https:\/\/doi.org\/10.1007\/s12035-016-0114-x","journal-title":"Mol Neurobiol"},{"key":"1788_CR37","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1756-6606-2-5","volume":"2","author":"V Cullen","year":"2009","unstructured":"Cullen V, Lindfors M, Ng J, Paetau A, Swinton E, Kolodziej P, Boston H, Saftig P, Woulfe J, Feany MB, Myllykangas L, Schlossmacher MG, Tyynela J (2009) Cathepsin D expression level affects alpha-synuclein processing, aggregation, and toxicity in vivo. Mol Brain 2:5. https:\/\/doi.org\/10.1186\/1756-6606-2-5","journal-title":"Mol Brain"},{"key":"1788_CR38","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1750-1326-4-34","volume":"4","author":"JP Daher","year":"2009","unstructured":"Daher JP, Ying M, Banerjee R, McDonald RS, Hahn MD, Yang L, Flint Beal M, Thomas B, Dawson VL, Dawson TM, Moore DJ (2009) Conditional transgenic mice expressing C-terminally truncated human alpha-synuclein (alphaSyn119) exhibit reduced striatal dopamine without loss of nigrostriatal pathway dopaminergic neurons. Mol Neurodegener 4:34. https:\/\/doi.org\/10.1186\/1750-1326-4-34","journal-title":"Mol Neurodegener"},{"key":"1788_CR39","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.nbd.2014.06.009","volume":"70","author":"KD Dave","year":"2014","unstructured":"Dave KD, De Silva S, Sheth NP, Ramboz S, Beck MJ, Quang C, Switzer RC 3rd, Ahmad SO, Sunkin SM, Walker D, Cui X, Fisher DA, McCoy AM, Gamber K, Ding X, Goldberg MS, Benkovic SA, Haupt M, Baptista MA, Fiske BK, Sherer TB, Frasier MA (2014) Phenotypic characterization of recessive gene knockout rat models of Parkinson\u2019s disease. Neurobiol Dis 70:190\u2013203. https:\/\/doi.org\/10.1016\/j.nbd.2014.06.009","journal-title":"Neurobiol Dis"},{"key":"1788_CR40","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1172\/JCI200317575","volume":"111","author":"TM Dawson","year":"2003","unstructured":"Dawson TM, Dawson VL (2003) Rare genetic mutations shed light on the pathogenesis of Parkinson disease. J Clin Investig 111:145\u2013151. https:\/\/doi.org\/10.1172\/JCI17575","journal-title":"J Clin Investig"},{"issue":"Suppl 1","key":"1788_CR41","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.1002\/mds.22798","volume":"25","author":"TM Dawson","year":"2010","unstructured":"Dawson TM, Dawson VL (2010) The role of parkin in familial and sporadic Parkinson\u2019s disease. Mov Disord 25(Suppl 1):S32\u2013S39. https:\/\/doi.org\/10.1002\/mds.22798","journal-title":"Mov Disord"},{"key":"1788_CR42","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.nbd.2011.12.013","volume":"45","author":"M Decressac","year":"2012","unstructured":"Decressac M, Mattsson B, Lundblad M, Weikop P, Bjorklund A (2012) Progressive neurodegenerative and behavioural changes induced by AAV-mediated overexpression of alpha-synuclein in midbrain dopamine neurons. Neurobiol Dis 45:939\u2013953. https:\/\/doi.org\/10.1016\/j.nbd.2011.12.013","journal-title":"Neurobiol Dis"},{"key":"1788_CR43","doi-asserted-by":"publisher","first-page":"12535","DOI":"10.1523\/JNEUROSCI.1920-10.2010","volume":"30","author":"B Dehay","year":"2010","unstructured":"Dehay B, Bove J, Rodriguez-Muela N, Perier C, Recasens A, Boya P, Vila M (2010) Pathogenic lysosomal depletion in Parkinson\u2019s disease. J Neurosci 30:12535\u201312544. https:\/\/doi.org\/10.1523\/Jneurosci.1920-10.2010","journal-title":"J Neurosci"},{"key":"1788_CR44","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1002\/mds.25462","volume":"28","author":"B Dehay","year":"2013","unstructured":"Dehay B, Martinez-Vicente M, Caldwell GA, Caldwell KA, Yue Z, Cookson MR, Klein C, Vila M, Bezard E (2013) Lysosomal impairment in Parkinson\u2019s disease. Mov Disord 28:725\u2013732. https:\/\/doi.org\/10.1002\/mds.25462","journal-title":"Mov Disord"},{"key":"1788_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2017.07.033","author":"DW Dickson","year":"2017","unstructured":"Dickson DW (2017) Neuropathology of Parkinson disease. Parkinsonism Relat Disord. https:\/\/doi.org\/10.1016\/j.parkreldis.2017.07.033","journal-title":"Parkinsonism Relat Disord"},{"key":"1788_CR46","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.neuro.2006.07.009","volume":"27","author":"LM Domico","year":"2006","unstructured":"Domico LM, Zeevalk GD, Bernard LP, Cooper KR (2006) Acute neurotoxic effects of mancozeb and maneb in mesencephalic neuronal cultures are associated with mitochondrial dysfunction. Neurotoxicology 27:816\u2013825. https:\/\/doi.org\/10.1016\/j.neuro.2006.07.009","journal-title":"Neurotoxicology"},{"key":"1788_CR47","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1046\/j.0022-3042.2001.00676.x","volume":"80","author":"W Duan","year":"2002","unstructured":"Duan W, Ladenheim B, Cutler RG, Kruman II, Cadet JL, Mattson MP (2002) Dietary folate deficiency and elevated homocysteine levels endanger dopaminergic neurons in models of Parkinson\u2019s disease. J Neurochem 80:101\u2013110","journal-title":"J Neurochem"},{"key":"1788_CR48","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.cell.2015.08.069","volume":"163","author":"P Ejlerskov","year":"2015","unstructured":"Ejlerskov P, Hultberg JG, Wang J, Carlsson R, Ambjorn M, Kuss M, Liu Y, Porcu G, Kolkova K, Friis Rundsten C, Ruscher K, Pakkenberg B, Goldmann T, Loreth D, Prinz M, Rubinsztein DC, Issazadeh-Navikas S (2015) Lack of neuronal IFN-beta-IFNAR causes Lewy body- and Parkinson\u2019s disease-like dementia. Cell 163:324\u2013339. https:\/\/doi.org\/10.1016\/j.cell.2015.08.069","journal-title":"Cell"},{"key":"1788_CR49","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1073\/pnas.0605208103","volume":"104","author":"MI Ekstrand","year":"2007","unstructured":"Ekstrand MI, Terzioglu M, Galter D, Zhu S, Hofstetter C, Lindqvist E, Thams S, Bergstrand A, Hansson FS, Trifunovic A, Hoffer B, Cullheim S, Mohammed AH, Olson L, Larsson NG (2007) Progressive parkinsonism in mice with respiratory-chain-deficient dopamine neurons. Proc Natl Acad Sci USA 104:1325\u20131330. https:\/\/doi.org\/10.1073\/pnas.0605208103","journal-title":"Proc Natl Acad Sci USA"},{"key":"1788_CR50","doi-asserted-by":"publisher","first-page":"35104","DOI":"10.1074\/jbc.M111.247965","volume":"286","author":"KL Emmer","year":"2011","unstructured":"Emmer KL, Waxman EA, Covy JP, Giasson BI (2011) E46K human alpha-synuclein transgenic mice develop Lewy-like and tau pathology associated with age-dependent, detrimental motor impairment. J Biol Chem 286:35104\u201335118. https:\/\/doi.org\/10.1074\/jbc.M111.247965","journal-title":"J Biol Chem"},{"key":"1788_CR51","doi-asserted-by":"publisher","first-page":"17483","DOI":"10.1073\/pnas.0708086104","volume":"104","author":"IB Enquist","year":"2007","unstructured":"Enquist IB, Lo Bianco C, Ooka A, Nilsson E, Mansson JE, Ehinger M, Richter J, Brady RO, Kirik D, Karlsson S (2007) Murine models of acute neuronopathic Gaucher disease. Proc Natl Acad Sci USA 104:17483\u201317488. https:\/\/doi.org\/10.1073\/pnas.0708086104","journal-title":"Proc Natl Acad Sci USA"},{"key":"1788_CR52","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.neulet.2014.01.033","volume":"563","author":"VD Escobar","year":"2014","unstructured":"Escobar VD, Kuo YM, Orrison BM, Giasson BI, Nussbaum RL (2014) Transgenic mice expressing S129 phosphorylation mutations in alpha-synuclein. Neurosci Lett 563:96\u2013100. https:\/\/doi.org\/10.1016\/j.neulet.2014.01.033","journal-title":"Neurosci Lett"},{"key":"1788_CR53","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1002\/ana.10846","volume":"55","author":"M Farrer","year":"2004","unstructured":"Farrer M, Kachergus J, Forno L, Lincoln S, Wang DS, Hulihan M, Maraganore D, Gwinn-Hardy K, Wszolek Z, Dickson D, Langston JW (2004) Comparison of kindreds with parkinsonism and alpha-synuclein genomic multiplications. Ann Neurol 55:174\u2013179. https:\/\/doi.org\/10.1002\/ana.10846","journal-title":"Ann Neurol"},{"key":"1788_CR54","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1002\/syn.20456","volume":"61","author":"PO Fernagut","year":"2007","unstructured":"Fernagut PO, Hutson CB, Fleming SM, Tetreaut NA, Salcedo J, Masliah E, Chesselet MF (2007) Behavioral and histopathological consequences of paraquat intoxication in mice: effects of alpha-synuclein over-expression. Synapse 61:991\u20131001. https:\/\/doi.org\/10.1002\/syn.20456","journal-title":"Synapse"},{"key":"1788_CR55","doi-asserted-by":"publisher","first-page":"436813","DOI":"10.4061\/2011\/436813","volume":"2011","author":"CC Ferrari","year":"2011","unstructured":"Ferrari CC, Tarelli R (2011) Parkinson\u2019s disease and systemic inflammation. Parkinsons Dis 2011:436813. https:\/\/doi.org\/10.4061\/2011\/436813","journal-title":"Parkinsons Dis"},{"key":"1788_CR56","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.nbd.2014.08.024","volume":"71","author":"K Fifel","year":"2014","unstructured":"Fifel K, Cooper HM (2014) Loss of dopamine disrupts circadian rhythms in a mouse model of Parkinson\u2019s disease. Neurobiol Dis 71:359\u2013369. https:\/\/doi.org\/10.1016\/j.nbd.2014.08.024","journal-title":"Neurobiol Dis"},{"key":"1788_CR57","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1016\/S0891-5849(02)01169-3","volume":"33","author":"VA Fitsanakis","year":"2002","unstructured":"Fitsanakis VA, Amarnath V, Moore JT, Montine KS, Zhang J, Montine TJ (2002) Catalysis of catechol oxidation by metal-dithiocarbamate complexes in pesticides. Free Radic Biol Med 33:1714\u20131723","journal-title":"Free Radic Biol Med"},{"key":"1788_CR58","doi-asserted-by":"publisher","first-page":"3413","DOI":"10.1073\/pnas.0409713102","volume":"102","author":"F Fornai","year":"2005","unstructured":"Fornai F, Schluter OM, Lenzi P, Gesi M, Ruffoli R, Ferrucci M, Lazzeri G, Busceti CL, Pontarelli F, Battaglia G, Pellegrini A, Nicoletti F, Ruggieri S, Paparelli A, Sudhof TC (2005) Parkinson-like syndrome induced by continuous MPTP infusion: convergent roles of the ubiquitin-proteasome system and alpha-synuclein. Proc Natl Acad Sci USA 102:3413\u20133418. https:\/\/doi.org\/10.1073\/pnas.0409713102","journal-title":"Proc Natl Acad Sci USA"},{"key":"1788_CR59","first-page":"600","volume":"60","author":"LS Forno","year":"1993","unstructured":"Forno LS, DeLanney LE, Irwin I, Langston JW (1993) Similarities and differences between MPTP-induced parkinsonsim and Parkinson\u2019s disease. Neuropathologic considerations. Adv Neurol 60:600\u2013608","journal-title":"Adv Neurol"},{"key":"1788_CR60","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1177\/1073858415574600","volume":"22","author":"S Franco-Iborra","year":"2016","unstructured":"Franco-Iborra S, Vila M, Perier C (2016) The Parkinson disease mitochondrial hypothesis: where are we at? Neuroscientist 22:266\u2013277. https:\/\/doi.org\/10.1177\/1073858415574600","journal-title":"Neuroscientist"},{"key":"1788_CR61","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1002\/ana.21288","volume":"63","author":"DM Gash","year":"2008","unstructured":"Gash DM, Rutland K, Hudson NL, Sullivan PG, Bing G, Cass WA, Pandya JD, Liu M, Choi DY, Hunter RL, Gerhardt GA, Smith CD, Slevin JT, Prince TS (2008) Trichloroethylene: Parkinsonism and complex 1 mitochondrial neurotoxicity. Ann Neurol 63:184\u2013192. https:\/\/doi.org\/10.1002\/ana.21288","journal-title":"Ann Neurol"},{"key":"1788_CR62","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S0896-6273(02)00682-7","volume":"34","author":"BI Giasson","year":"2002","unstructured":"Giasson BI, Duda JE, Quinn SM, Zhang B, Trojanowski JQ, Lee VM (2002) Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein. Neuron 34:521\u2013533","journal-title":"Neuron"},{"key":"1788_CR63","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/S1044-7431(03)00198-2","volume":"24","author":"S Gispert","year":"2003","unstructured":"Gispert S, Del Turco D, Garrett L, Chen A, Bernard DJ, Hamm-Clement J, Korf HW, Deller T, Braak H, Auburger G, Nussbaum RL (2003) Transgenic mice expressing mutant A53T human alpha-synuclein show neuronal dysfunction in the absence of aggregate formation. Mol Cell Neurosci 24:419\u2013429","journal-title":"Mol Cell Neurosci"},{"key":"1788_CR64","doi-asserted-by":"publisher","first-page":"e5777","DOI":"10.1371\/journal.pone.0005777","volume":"4","author":"S Gispert","year":"2009","unstructured":"Gispert S, Ricciardi F, Kurz A, Azizov M, Hoepken HH, Becker D, Voos W, Leuner K, Muller WE, Kudin AP, Kunz WS, Zimmermann A, Roeper J, Wenzel D, Jendrach M, Garcia-Arencibia M, Fernandez-Ruiz J, Huber L, Rohrer H, Barrera M, Reichert AS, Rub U, Chen A, Nussbaum RL, Auburger G (2009) Parkinson phenotype in aged PINK1-deficient mice is accompanied by progressive mitochondrial dysfunction in absence of neurodegeneration. PLoS One 4:e5777. https:\/\/doi.org\/10.1371\/journal.pone.0005777","journal-title":"PLoS One"},{"key":"1788_CR65","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.expneurol.2012.01.002","volume":"235","author":"L Glasl","year":"2012","unstructured":"Glasl L, Kloos K, Giesert F, Roethig A, Di Benedetto B, Kuhn R, Zhang J, Hafen U, Zerle J, Hofmann A, de Angelis MH, Winklhofer KF, Holter SM, Vogt Weisenhorn DM, Wurst W (2012) Pink1-deficiency in mice impairs gait, olfaction and serotonergic innervation of the olfactory bulb. Exp Neurol 235:214\u2013227. https:\/\/doi.org\/10.1016\/j.expneurol.2012.01.002","journal-title":"Exp Neurol"},{"key":"1788_CR66","doi-asserted-by":"publisher","first-page":"43628","DOI":"10.1074\/jbc.M308947200","volume":"278","author":"MS Goldberg","year":"2003","unstructured":"Goldberg MS, Fleming SM, Palacino JJ, Cepeda C, Lam HA, Bhatnagar A, Meloni EG, Wu N, Ackerson LC, Klapstein GJ, Gajendiran M, Roth BL, Chesselet MF, Maidment NT, Levine MS, Shen J (2003) Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons. J Biol Chem 278:43628\u201343635. https:\/\/doi.org\/10.1074\/jbc.M308947200","journal-title":"J Biol Chem"},{"key":"1788_CR67","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.neuron.2005.01.041","volume":"45","author":"MS Goldberg","year":"2005","unstructured":"Goldberg MS, Pisani A, Haburcak M, Vortherms TA, Kitada T, Costa C, Tong Y, Martella G, Tscherter A, Martins A, Bernardi G, Roth BL, Pothos EN, Calabresi P, Shen J (2005) Nigrostriatal dopaminergic deficits and hypokinesia caused by inactivation of the familial Parkinsonism-linked gene DJ-1. Neuron 45:489\u2013496. https:\/\/doi.org\/10.1016\/j.neuron.2005.01.041","journal-title":"Neuron"},{"key":"1788_CR68","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1146\/annurev-pharmtox-011613-135937","volume":"54","author":"SM Goldman","year":"2014","unstructured":"Goldman SM (2014) Environmental toxins and Parkinson\u2019s disease. Annu Rev Pharmacol Toxicol 54:141\u2013164. https:\/\/doi.org\/10.1146\/annurev-pharmtox-011613-135937","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"1788_CR69","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1002\/ana.22629","volume":"71","author":"SM Goldman","year":"2012","unstructured":"Goldman SM, Quinlan PJ, Ross GW, Marras C, Meng C, Bhudhikanok GS, Comyns K, Korell M, Chade AR, Kasten M, Priestley B, Chou KL, Fernandez HH, Cambi F, Langston JW, Tanner CM (2012) Solvent exposures and Parkinson disease risk in twins. Ann Neurol 71:776\u2013784. https:\/\/doi.org\/10.1002\/ana.22629","journal-title":"Ann Neurol"},{"key":"1788_CR70","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S0197-4580(02)00091-X","volume":"24","author":"T Gomez-Isla","year":"2003","unstructured":"Gomez-Isla T, Irizarry MC, Mariash A, Cheung B, Soto O, Schrump S, Sondel J, Kotilinek L, Day J, Schwarzschild MA, Cha JH, Newell K, Miller DW, Ueda K, Young AB, Hyman BT, Ashe KH (2003) Motor dysfunction and gliosis with preserved dopaminergic markers in human alpha-synuclein A30P transgenic mice. Neurobiol Aging 24:245\u2013258","journal-title":"Neurobiol Aging"},{"key":"1788_CR71","doi-asserted-by":"publisher","first-page":"324521","DOI":"10.1155\/2012\/324521","volume":"2012","author":"P Gomez-Suaga","year":"2012","unstructured":"Gomez-Suaga P, Fdez E, Blanca Ramirez M, Hilfiker S (2012) A link between autophagy and the pathophysiology of LRRK2 in Parkinson\u2019s disease. Parkinsons Dis 2012:324521. https:\/\/doi.org\/10.1155\/2012\/324521","journal-title":"Parkinsons Dis"},{"key":"1788_CR72","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.neuron.2012.05.018","volume":"75","author":"LE Gonzalez-Reyes","year":"2012","unstructured":"Gonzalez-Reyes LE, Verbitsky M, Blesa J, Jackson-Lewis V, Paredes D, Tillack K, Phani S, Kramer ER, Przedborski S, Kottmann AH (2012) Sonic hedgehog maintains cellular and neurochemical homeostasis in the adult nigrostriatal circuit. Neuron 75:306\u2013319. https:\/\/doi.org\/10.1016\/j.neuron.2012.05.018","journal-title":"Neuron"},{"key":"1788_CR73","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1096\/fj.10-173625","volume":"25","author":"CH Good","year":"2011","unstructured":"Good CH, Hoffman AF, Hoffer BJ, Chefer VI, Shippenberg TS, Backman CM, Larsson NG, Olson L, Gellhaar S, Galter D, Lupica CR (2011) Impaired nigrostriatal function precedes behavioral deficits in a genetic mitochondrial model of Parkinson\u2019s disease. Faseb J 25:1333\u20131344. https:\/\/doi.org\/10.1096\/fj.10-173625","journal-title":"Faseb J"},{"key":"1788_CR74","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s00401-014-1345-4","volume":"128","author":"V Grozdanov","year":"2014","unstructured":"Grozdanov V, Bliederhaeuser C, Ruf WP, Roth V, Fundel-Clemens K, Zondler L, Brenner D, Martin-Villalba A, Hengerer B, Kassubek J, Ludolph AC, Weishaupt JH, Danzer KM (2014) Inflammatory dysregulation of blood monocytes in Parkinson\u2019s disease patients. Acta Neuropathol 128:651\u2013663. https:\/\/doi.org\/10.1007\/s00401-014-1345-4","journal-title":"Acta Neuropathol"},{"key":"1788_CR75","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1093\/jnen\/61.7.634","volume":"61","author":"G Gu","year":"2002","unstructured":"Gu G, Reyes PE, Golden GT, Woltjer RL, Hulette C, Montine TJ, Zhang J (2002) Mitochondrial DNA deletions\/rearrangements in parkinson disease and related neurodegenerative disorders. J Neuropathol Exp Neurol 61:634\u2013639","journal-title":"J Neuropathol Exp Neurol"},{"key":"1788_CR76","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1046\/j.1468-1331.1999.650609.x","volume":"6","author":"D Guehl","year":"1999","unstructured":"Guehl D, Bezard E, Dovero S, Boraud T, Bioulac B, Gross C (1999) Trichloroethylene and parkinsonism: a human and experimental observation. Eur J Neurol 6:609\u2013611","journal-title":"Eur J Neurol"},{"key":"1788_CR77","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.neulet.2016.05.039","volume":"627","author":"JC Gully","year":"2016","unstructured":"Gully JC, Sergeyev VG, Bhootada Y, Mendez-Gomez H, Meyers CA, Zolotukhin S, Gorbatyuk MS, Gorbatyuk OS (2016) Up-regulation of activating transcription factor 4 induces severe loss of dopamine nigral neurons in a rat model of Parkinson\u2019s disease. Neurosci Lett 627:36\u201341. https:\/\/doi.org\/10.1016\/j.neulet.2016.05.039","journal-title":"Neurosci Lett"},{"key":"1788_CR78","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.expneurol.2014.11.003","volume":"264","author":"K Hall","year":"2015","unstructured":"Hall K, Yang S, Sauchanka O, Spillantini MG, Anichtchik O (2015) Behavioural deficits in transgenic mice expressing human truncated (1\u2013120 amino acid) alpha-synuclein. Exp Neurol 264:8\u201313. https:\/\/doi.org\/10.1016\/j.expneurol.2014.11.003","journal-title":"Exp Neurol"},{"key":"1788_CR79","doi-asserted-by":"publisher","first-page":"e47950","DOI":"10.1371\/journal.pone.0047950","volume":"7","author":"K Hashida","year":"2012","unstructured":"Hashida K, Kitao Y, Sudo H, Awa Y, Maeda S, Mori K, Takahashi R, Iinuma M, Hori O (2012) ATF6alpha promotes astroglial activation and neuronal survival in a chronic mouse model of Parkinson\u2019s disease. PLoS One 7:e47950. https:\/\/doi.org\/10.1371\/journal.pone.0047950","journal-title":"PLoS One"},{"key":"1788_CR80","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.bbrc.2007.01.043","volume":"354","author":"JJ Hoozemans","year":"2007","unstructured":"Hoozemans JJ, van Haastert ES, Eikelenboom P, de Vos RA, Rozemuller JM, Scheper W (2007) Activation of the unfolded protein response in Parkinson\u2019s disease. Biochem Biophys Res Commun 354:707\u2013711. https:\/\/doi.org\/10.1016\/j.bbrc.2007.01.043","journal-title":"Biochem Biophys Res Commun"},{"key":"1788_CR81","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.tig.2005.08.012","volume":"21","author":"N Howell","year":"2005","unstructured":"Howell N, Elson JL, Chinnery PF, Turnbull DM (2005) mtDNA mutations and common neurodegenerative disorders. Trends Genet 21:583\u2013586. https:\/\/doi.org\/10.1016\/j.tig.2005.08.012","journal-title":"Trends Genet"},{"key":"1788_CR82","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0169-328X(03)00162-1","volume":"114","author":"DY Hwang","year":"2003","unstructured":"Hwang DY, Ardayfio P, Kang UJ, Semina EV, Kim KS (2003) Selective loss of dopaminergic neurons in the substantia nigra of Pitx3-deficient aphakia mice. Brain Res Mol Brain Res 114:123\u2013131","journal-title":"Brain Res Mol Brain Res"},{"key":"1788_CR83","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1007\/s11064-012-0838-6","volume":"37","author":"J Iglesias-Gonzalez","year":"2012","unstructured":"Iglesias-Gonzalez J, Sanchez-Iglesias S, Mendez-Alvarez E, Rose S, Hikima A, Jenner P, Soto-Otero R (2012) Differential toxicity of 6-hydroxydopamine in SH-SY5Y human neuroblastoma cells and rat brain mitochondria: protective role of catalase and superoxide dismutase. Neurochem Res 37:2150\u20132160. https:\/\/doi.org\/10.1007\/s11064-012-0838-6","journal-title":"Neurochem Res"},{"key":"1788_CR84","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.brainres.2008.10.011","volume":"1250","author":"M Ikeda","year":"2009","unstructured":"Ikeda M, Kawarabayashi T, Harigaya Y, Sasaki A, Yamada S, Matsubara E, Murakami T, Tanaka Y, Kurata T, Wuhua X, Ueda K, Kuribara H, Ikarashi Y, Nakazato Y, Okamoto K, Abe K, Shoji M (2009) Motor impairment and aberrant production of neurochemicals in human alpha-synuclein A30P+ A53T transgenic mice with alpha-synuclein pathology. Brain Res 1250:232\u2013241. https:\/\/doi.org\/10.1016\/j.brainres.2008.10.011","journal-title":"Brain Res"},{"key":"1788_CR85","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1097\/NEN.0b013e318186de48","volume":"67","author":"M Ikemura","year":"2008","unstructured":"Ikemura M, Saito Y, Sengoku R, Sakiyama Y, Hatsuta H, Kanemaru K, Sawabe M, Arai T, Ito G, Iwatsubo T, Fukayama M, Murayama S (2008) Lewy body pathology involves cutaneous nerves. J Neuropathol Exp Neurol 67:945\u2013953. https:\/\/doi.org\/10.1097\/NEN.0b013e318186de48","journal-title":"J Neuropathol Exp Neurol"},{"key":"1788_CR86","doi-asserted-by":"publisher","first-page":"E4016","DOI":"10.1073\/pnas.1309143110","volume":"110","author":"S Janezic","year":"2013","unstructured":"Janezic S, Threlfell S, Dodson PD, Dowie MJ, Taylor TN, Potgieter D, Parkkinen L, Senior SL, Anwar S, Ryan B, Deltheil T, Kosillo P, Cioroch M, Wagner K, Ansorge O, Bannerman DM, Bolam JP, Magill PJ, Cragg SJ, Wade-Martins R (2013) Deficits in dopaminergic transmission precede neuron loss and dysfunction in a new Parkinson model. Proc Natl Acad Sci USA 110:E4016\u2013E4025. https:\/\/doi.org\/10.1073\/pnas.1309143110","journal-title":"Proc Natl Acad Sci USA"},{"key":"1788_CR87","first-page":"297","volume":"46","author":"K Jellinger","year":"1995","unstructured":"Jellinger K, Linert L, Kienzl E, Herlinger E, Youdim MB (1995) Chemical evidence for 6-hydroxydopamine to be an endogenous toxic factor in the pathogenesis of Parkinson\u2019s disease. J Neural Transm Suppl 46:297\u2013314","journal-title":"J Neural Transm Suppl"},{"key":"1788_CR88","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/1750-1326-5-56","volume":"5","author":"P Jiang","year":"2010","unstructured":"Jiang P, Gan M, Ebrahim AS, Lin WL, Melrose HL, Yen SH (2010) ER stress response plays an important role in aggregation of alpha-synuclein. Mol Neurodegener 5:56. https:\/\/doi.org\/10.1186\/1750-1326-5-56","journal-title":"Mol Neurodegener"},{"key":"1788_CR89","doi-asserted-by":"publisher","first-page":"268","DOI":"10.3389\/fnagi.2014.00268","volume":"6","author":"P Jiang","year":"2014","unstructured":"Jiang P, Gan M, Lin WL, Yen SH (2014) Nutrient deprivation induces alpha-synuclein aggregation through endoplasmic reticulum stress response and SREBP2 pathway. Front Aging Neurosci 6:268. https:\/\/doi.org\/10.3389\/fnagi.2014.00268","journal-title":"Front Aging Neurosci"},{"key":"1788_CR90","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s00401-016-1542-4","volume":"132","author":"P Jiang","year":"2016","unstructured":"Jiang P, Gan M, Yen SH, Moussaud S, McLean PJ, Dickson DW (2016) Proaggregant nuclear factor(s) trigger rapid formation of alpha-synuclein aggregates in apoptotic neurons. Acta Neuropathol 132:77\u201391. https:\/\/doi.org\/10.1007\/s00401-016-1542-4","journal-title":"Acta Neuropathol"},{"key":"1788_CR91","doi-asserted-by":"publisher","first-page":"15923","DOI":"10.1523\/JNEUROSCI.3910-09.2009","volume":"29","author":"B Kadkhodaei","year":"2009","unstructured":"Kadkhodaei B, Ito T, Joodmardi E, Mattsson B, Rouillard C, Carta M, Muramatsu S, Sumi-Ichinose C, Nomura T, Metzger D, Chambon P, Lindqvist E, Larsson NG, Olson L, Bjorklund A, Ichinose H, Perlmann T (2009) Nurr1 is required for maintenance of maturing and adult midbrain dopamine neurons. J Neurosci 29:15923\u201315932. https:\/\/doi.org\/10.1523\/JNEUROSCI.3910-09.2009","journal-title":"J Neurosci"},{"key":"1788_CR92","doi-asserted-by":"publisher","first-page":"15240","DOI":"10.1074\/jbc.M312497200","volume":"279","author":"SV Kalivendi","year":"2004","unstructured":"Kalivendi SV, Cunningham S, Kotamraju S, Joseph J, Hillard CJ, Kalyanaraman B (2004) Alpha-synuclein up-regulation and aggregation during MPP+-induced apoptosis in neuroblastoma cells: intermediacy of transferrin receptor iron and hydrogen peroxide. J Biol Chem 279:15240\u201315247. https:\/\/doi.org\/10.1074\/jbc.M312497200","journal-title":"J Biol Chem"},{"key":"1788_CR93","doi-asserted-by":"publisher","first-page":"5256","DOI":"10.1523\/JNEUROSCI.0984-06.2006","volume":"26","author":"PM Keeney","year":"2006","unstructured":"Keeney PM, Xie J, Capaldi RA, Bennett JP Jr (2006) Parkinson\u2019s disease brain mitochondrial complex I has oxidatively damaged subunits and is functionally impaired and misassembled. J Neurosci 26:5256\u20135264. https:\/\/doi.org\/10.1523\/JNEUROSCI.0984-06.2006","journal-title":"J Neurosci"},{"key":"1788_CR94","doi-asserted-by":"publisher","first-page":"5724","DOI":"10.1523\/JNEUROSCI.0632-14.2015","volume":"35","author":"LR Kett","year":"2015","unstructured":"Kett LR, Stiller B, Bernath MM, Tasset I, Blesa J, Jackson-Lewis V, Chan RB, Zhou B, Di Paolo G, Przedborski S, Cuervo AM, Dauer WT (2015) alpha-Synuclein-independent histopathological and motor deficits in mice lacking the endolysosomal Parkinsonism protein Atp13a2. J Neurosci 35:5724\u20135742. https:\/\/doi.org\/10.1523\/JNEUROSCI.0632-14.2015","journal-title":"J Neurosci"},{"key":"1788_CR95","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.1016\/j.neurobiolaging.2015.05.008","volume":"36","author":"HW Kim","year":"2015","unstructured":"Kim HW, Choi WS, Sorscher N, Park HJ, Tronche F, Palmiter RD, Xia Z (2015) Genetic reduction of mitochondrial complex I function does not lead to loss of dopamine neurons in vivo. Neurobiol Aging 36:2617\u20132627. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2015.05.008","journal-title":"Neurobiol Aging"},{"key":"1788_CR96","doi-asserted-by":"publisher","first-page":"5215","DOI":"10.1073\/pnas.0501282102","volume":"102","author":"RH Kim","year":"2005","unstructured":"Kim RH, Smith PD, Aleyasin H, Hayley S, Mount MP, Pownall S, Wakeham A, You-Ten AJ, Kalia SK, Horne P, Westaway D, Lozano AM, Anisman H, Park DS, Mak TW (2005) Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine (MPTP) and oxidative stress. Proc Natl Acad Sci USA 102:5215\u20135220. https:\/\/doi.org\/10.1073\/pnas.0501282102","journal-title":"Proc Natl Acad Sci USA"},{"key":"1788_CR97","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1523\/JNEUROSCI.22-07-02780.2002","volume":"22","author":"D Kirik","year":"2002","unstructured":"Kirik D, Rosenblad C, Burger C, Lundberg C, Johansen TE, Muzyczka N, Mandel RJ, Bjorklund A (2002) Parkinson-like neurodegeneration induced by targeted overexpression of alpha-synuclein in the nigrostriatal system. J Neurosci 22:2780\u20132791","journal-title":"J Neurosci"},{"key":"1788_CR98","doi-asserted-by":"publisher","first-page":"a008888","DOI":"10.1101\/cshperspect.a008888","volume":"2","author":"C Klein","year":"2012","unstructured":"Klein C, Westenberger A (2012) Genetics of Parkinson\u2019s disease. Cold Spring Harb Perspect Med 2:a008888. https:\/\/doi.org\/10.1101\/cshperspect.a008888","journal-title":"Cold Spring Harb Perspect Med"},{"key":"1788_CR99","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1002\/ana.410320612","volume":"32","author":"D Krige","year":"1992","unstructured":"Krige D, Carroll MT, Cooper JM, Marsden CD, Schapira AH (1992) Platelet mitochondrial function in Parkinson\u2019s disease. The Royal Kings and Queens Parkinson Disease Research Group. Ann Neurol 32:782\u2013788. https:\/\/doi.org\/10.1002\/ana.410320612","journal-title":"Ann Neurol"},{"key":"1788_CR100","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1021\/bi026528t","volume":"42","author":"S Krishnan","year":"2003","unstructured":"Krishnan S, Chi EY, Wood SJ, Kendrick BS, Li C, Garzon-Rodriguez W, Wypych J, Randolph TW, Narhi LO, Biere AL, Citron M, Carpenter JF (2003) Oxidative dimer formation is the critical rate-limiting step for Parkinson\u2019s disease alpha-synuclein fibrillogenesis. Biochemistry 42:829\u2013837. https:\/\/doi.org\/10.1021\/bi026528t","journal-title":"Biochemistry"},{"key":"1788_CR101","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1159\/000007984","volume":"40","author":"W Kuhn","year":"1998","unstructured":"Kuhn W, Roebroek R, Blom H, van Oppenraaij D, Przuntek H, Kretschmer A, Buttner T, Woitalla D, Muller T (1998) Elevated plasma levels of homocysteine in Parkinson\u2019s disease. Eur Neurol 40:225\u2013227","journal-title":"Eur Neurol"},{"key":"1788_CR102","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1007\/s00702-014-1185-3","volume":"121","author":"A Kupsch","year":"2014","unstructured":"Kupsch A, Schmidt W, Gizatullina Z, Debska-Vielhaber G, Voges J, Striggow F, Panther P, Schwegler H, Heinze HJ, Vielhaber S, Gellerich FN (2014) 6-Hydroxydopamine impairs mitochondrial function in the rat model of Parkinson\u2019s disease: respirometric, histological, and behavioral analyses. J Neural Transm (Vienna) 121:1245\u20131257. https:\/\/doi.org\/10.1007\/s00702-014-1185-3","journal-title":"J Neural Transm (Vienna)"},{"key":"1788_CR103","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1002\/ana.20834","volume":"59","author":"JW Langston","year":"2006","unstructured":"Langston JW (2006) The Parkinson\u2019s complex: parkinsonism is just the tip of the iceberg. Ann Neurol 59:591\u2013596. https:\/\/doi.org\/10.1002\/ana.20834","journal-title":"Ann Neurol"},{"key":"1788_CR104","first-page":"49","volume":"100","author":"JW Langston","year":"1984","unstructured":"Langston JW, Langston EB, Irwin I (1984) MPTP-induced parkinsonism in human and non-human primates\u2013clinical and experimental aspects. Acta Neurol Scand Suppl 100:49\u201354","journal-title":"Acta Neurol Scand Suppl"},{"key":"1788_CR105","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.neurobiolaging.2005.12.005","volume":"28","author":"E Lauwers","year":"2007","unstructured":"Lauwers E, Beque D, Van Laere K, Nuyts J, Bormans G, Mortelmans L, Casteels C, Vercammen L, Bockstael O, Nuttin B, Debyser Z, Baekelandt V (2007) Non-invasive imaging of neuropathology in a rat model of alpha-synuclein overexpression. Neurobiol Aging 28:248\u2013257. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2005.12.005","journal-title":"Neurobiol Aging"},{"key":"1788_CR106","doi-asserted-by":"publisher","first-page":"8968","DOI":"10.1073\/pnas.132197599","volume":"99","author":"MK Lee","year":"2002","unstructured":"Lee MK, Stirling W, Xu Y, Xu X, Qui D, Mandir AS, Dawson TM, Copeland NG, Jenkins NA, Price DL (2002) Human alpha-synuclein-harboring familial Parkinson\u2019s disease-linked Ala-53 \u2192Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice. Proc Natl Acad Sci USA 99:8968\u20138973. https:\/\/doi.org\/10.1073\/pnas.132197599","journal-title":"Proc Natl Acad Sci USA"},{"key":"1788_CR107","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/26652","volume":"395","author":"E Leroy","year":"1998","unstructured":"Leroy E, Boyer R, Auburger G, Leube B, Ulm G, Mezey E, Harta G, Brownstein MJ, Jonnalagada S, Chernova T, Dehejia A, Lavedan C, Gasser T, Steinbach PJ, Wilkinson KD, Polymeropoulos MH (1998) The ubiquitin pathway in Parkinson\u2019s disease. Nature 395:451\u2013452. https:\/\/doi.org\/10.1038\/26652","journal-title":"Nature"},{"key":"1788_CR108","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1038\/nn.2349","volume":"12","author":"Y Li","year":"2009","unstructured":"Li Y, Liu W, Oo TF, Wang L, Tang Y, Jackson-Lewis V, Zhou C, Geghman K, Bogdanov M, Przedborski S, Beal MF, Burke RE, Li C (2009) Mutant LRRK2(R1441G) BAC transgenic mice recapitulate cardinal features of Parkinson\u2019s disease. Nat Neurosci 12:826\u2013828. https:\/\/doi.org\/10.1038\/nn.2349","journal-title":"Nat Neurosci"},{"key":"1788_CR109","doi-asserted-by":"publisher","first-page":"e1002548","DOI":"10.1371\/journal.pgen.1002548","volume":"8","author":"CM Lill","year":"2012","unstructured":"Lill CM, Roehr JT, McQueen MB, Kavvoura FK, Bagade S, Schjeide BM, Schjeide LM, Meissner E, Zauft U, Allen NC, Liu T, Schilling M, Anderson KJ, Beecham G, Berg D, Biernacka JM, Brice A, DeStefano AL, Do CB, Eriksson N, Factor SA, Farrer MJ, Foroud T, Gasser T, Hamza T, Hardy JA, Heutink P, Hill-Burns EM, Klein C, Latourelle JC, Maraganore DM, Martin ER, Martinez M, Myers RH, Nalls MA, Pankratz N, Payami H, Satake W, Scott WK, Sharma M, Singleton AB, Stefansson K, Toda T, Tung JY, Vance J, Wood NW, Zabetian CP, Young P, Tanzi RE, Khoury MJ, Zipp F, Lehrach H, Ioannidis JP, Bertram L (2012) Comprehensive research synopsis and systematic meta-analyses in Parkinson\u2019s disease genetics: the PDGene database. PLoS Genet 8:e1002548. https:\/\/doi.org\/10.1371\/journal.pgen.1002548","journal-title":"PLoS Genet"},{"key":"1788_CR110","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1586\/14789450.4.6.769","volume":"4","author":"KL Lim","year":"2007","unstructured":"Lim KL (2007) Ubiquitin-proteasome system dysfunction in Parkinson\u2019s disease: current evidence and controversies. Expert Rev Proteom 4:769\u2013781. https:\/\/doi.org\/10.1586\/14789450.4.6.769","journal-title":"Expert Rev Proteom"},{"key":"1788_CR111","doi-asserted-by":"publisher","first-page":"9248","DOI":"10.1523\/JNEUROSCI.1731-12.2012","volume":"32","author":"X Lin","year":"2012","unstructured":"Lin X, Parisiadou L, Sgobio C, Liu G, Yu J, Sun L, Shim H, Gu XL, Luo J, Long CX, Ding J, Mateo Y, Sullivan PH, Wu LG, Goldstein DS, Lovinger D, Cai H (2012) Conditional expression of Parkinson\u2019s disease-related mutant alpha-synuclein in the midbrain dopaminergic neurons causes progressive neurodegeneration and degradation of transcription factor nuclear receptor related 1. J Neurosci 32:9248\u20139264. https:\/\/doi.org\/10.1523\/JNEUROSCI.1731-12.2012","journal-title":"J Neurosci"},{"key":"1788_CR112","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1111\/j.1471-4159.2009.06497.x","volume":"112","author":"M Liu","year":"2010","unstructured":"Liu M, Choi DY, Hunter RL, Pandya JD, Cass WA, Sullivan PG, Kim HC, Gash DM, Bing G (2010) Trichloroethylene induces dopaminergic neurodegeneration in Fisher 344 rats. J Neurochem 112:773\u2013783. https:\/\/doi.org\/10.1111\/j.1471-4159.2009.06497.x","journal-title":"J Neurochem"},{"key":"1788_CR113","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.neuint.2011.03.013","volume":"58","author":"E Lorenc-Koci","year":"2011","unstructured":"Lorenc-Koci E, Lenda T, Antkiewicz-Michaluk L, Wardas J, Domin H, Smialowska M, Konieczny J (2011) Different effects of intranigral and intrastriatal administration of the proteasome inhibitor lactacystin on typical neurochemical and histological markers of Parkinson\u2019s disease in rats. Neurochem Int 58:839\u2013849. https:\/\/doi.org\/10.1016\/j.neuint.2011.03.013","journal-title":"Neurochem Int"},{"key":"1788_CR114","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1523\/JNEUROSCI.5351-08.2009","volume":"29","author":"XH Lu","year":"2009","unstructured":"Lu XH, Fleming SM, Meurers B, Ackerson LC, Mortazavi F, Lo V, Hernandez D, Sulzer D, Jackson GR, Maidment NT, Chesselet MF, Yang XW (2009) Bacterial artificial chromosome transgenic mice expressing a truncated mutant parkin exhibit age-dependent hypokinetic motor deficits, dopaminergic neuron degeneration, and accumulation of proteinase K-resistant alpha-synuclein. J Neurosci 29:1962\u20131976. https:\/\/doi.org\/10.1523\/JNEUROSCI.5351-08.2009","journal-title":"J Neurosci"},{"key":"1788_CR115","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1084\/jem.20112457","volume":"209","author":"KC Luk","year":"2012","unstructured":"Luk KC, Kehm VM, Zhang B, O\u2019Brien P, Trojanowski JQ, Lee VM (2012) Intracerebral inoculation of pathological alpha-synuclein initiates a rapidly progressive neurodegenerative alpha-synucleinopathy in mice. J Exp Med 209:975\u2013986. https:\/\/doi.org\/10.1084\/jem.20112457","journal-title":"J Exp Med"},{"issue":"Suppl 1","key":"1788_CR116","doi-asserted-by":"publisher","first-page":"S85","DOI":"10.1016\/S1353-8020(13)70022-1","volume":"20","author":"KC Luk","year":"2014","unstructured":"Luk KC, Lee VM (2014) Modeling Lewy pathology propagation in Parkinson\u2019s disease. Parkinsonism Relat Disord 20(Suppl 1):S85\u2013S87. https:\/\/doi.org\/10.1016\/S1353-8020(13)70022-1","journal-title":"Parkinsonism Relat Disord"},{"key":"1788_CR117","doi-asserted-by":"publisher","first-page":"a009357","DOI":"10.1101\/cshperspect.a009357","volume":"2","author":"MA Lynch-Day","year":"2012","unstructured":"Lynch-Day MA, Mao K, Wang K, Zhao M, Klionsky DJ (2012) The role of autophagy in Parkinson\u2019s disease. Cold Spring Harb Perspect Med 2:a009357. https:\/\/doi.org\/10.1101\/cshperspect.a009357","journal-title":"Cold Spring Harb Perspect Med"},{"key":"1788_CR118","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.nbd.2013.02.012","volume":"54","author":"R Magnoni","year":"2013","unstructured":"Magnoni R, Palmfeldt J, Christensen JH, Sand M, Maltecca F, Corydon TJ, West M, Casari G, Bross P (2013) Late onset motoneuron disorder caused by mitochondrial Hsp60 chaperone deficiency in mice. Neurobiol Dis 54:12\u201323. https:\/\/doi.org\/10.1016\/j.nbd.2013.02.012","journal-title":"Neurobiol Dis"},{"key":"1788_CR119","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.nbd.2007.03.014","volume":"27","author":"AB Manning-Bog","year":"2007","unstructured":"Manning-Bog AB, Caudle WM, Perez XA, Reaney SH, Paletzki R, Isla MZ, Chou VP, McCormack AL, Miller GW, Langston JW, Gerfen CR, Dimonte DA (2007) Increased vulnerability of nigrostriatal terminals in DJ-1-deficient mice is mediated by the dopamine transporter. Neurobiol Dis 27:141\u2013150. https:\/\/doi.org\/10.1016\/j.nbd.2007.03.014","journal-title":"Neurobiol Dis"},{"key":"1788_CR120","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1074\/jbc.C100560200","volume":"277","author":"AB Manning-Bog","year":"2002","unstructured":"Manning-Bog AB, McCormack AL, Li J, Uversky VN, Fink AL, Di Monte DA (2002) The herbicide paraquat causes up-regulation and aggregation of alpha-synuclein in mice: paraquat and alpha-synuclein. J Biol Chem 277:1641\u20131644. https:\/\/doi.org\/10.1074\/jbc.C100560200","journal-title":"J Biol Chem"},{"key":"1788_CR121","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1042\/BST20120126","volume":"40","author":"C Manzoni","year":"2012","unstructured":"Manzoni C (2012) LRRK2 and autophagy: a common pathway for disease. Biochem Soc Trans 40:1147\u20131151. https:\/\/doi.org\/10.1042\/BST20120126","journal-title":"Biochem Soc Trans"},{"key":"1788_CR122","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/ana.20017","volume":"55","author":"DM Maraganore","year":"2004","unstructured":"Maraganore DM, Lesnick TG, Elbaz A, Chartier-Harlin MC, Gasser T, Kruger R, Hattori N, Mellick GD, Quattrone A, Satoh J, Toda T, Wang J, Ioannidis JP, de Andrade M, Rocca WA (2004) UCHL1 is a Parkinson\u2019s disease susceptibility gene. Ann Neurol 55:512\u2013521. https:\/\/doi.org\/10.1002\/ana.20017","journal-title":"Ann Neurol"},{"key":"1788_CR123","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.expneurol.2008.11.001","volume":"215","author":"G Martella","year":"2009","unstructured":"Martella G, Platania P, Vita D, Sciamanna G, Cuomo D, Tassone A, Tscherter A, Kitada T, Bonsi P, Shen J, Pisani A (2009) Enhanced sensitivity to group II mGlu receptor activation at corticostriatal synapses in mice lacking the familial parkinsonism-linked genes PINK1 or Parkin. Exp Neurol 215:388\u2013396. https:\/\/doi.org\/10.1016\/j.expneurol.2008.11.001","journal-title":"Exp Neurol"},{"key":"1788_CR124","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1089\/ars.2011.4033","volume":"16","author":"TN Martinez","year":"2012","unstructured":"Martinez TN, Greenamyre JT (2012) Toxin models of mitochondrial dysfunction in Parkinson\u2019s disease. Antioxid Redox Signal 16:920\u2013934. https:\/\/doi.org\/10.1089\/ars.2011.4033","journal-title":"Antioxid Redox Signal"},{"key":"1788_CR125","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1126\/science.287.5456.1265","volume":"287","author":"E Masliah","year":"2000","unstructured":"Masliah E, Rockenstein E, Veinbergs I, Mallory M, Hashimoto M, Takeda A, Sagara Y, Sisk A, Mucke L (2000) Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders. Science 287:1265\u20131269","journal-title":"Science"},{"key":"1788_CR126","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1006\/nbdi.2001.0392","volume":"8","author":"Y Matsuoka","year":"2001","unstructured":"Matsuoka Y, Vila M, Lincoln S, McCormack A, Picciano M, LaFrancois J, Yu X, Dickson D, Langston WJ, McGowan E, Farrer M, Hardy J, Duff K, Przedborski S, Di Monte DA (2001) Lack of nigral pathology in transgenic mice expressing human alpha-synuclein driven by the tyrosine hydroxylase promoter. Neurobiol Dis 8:535\u2013539. https:\/\/doi.org\/10.1006\/nbdi.2001.0392","journal-title":"Neurobiol Dis"},{"key":"1788_CR127","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1006\/nbdi.2002.0507","volume":"10","author":"AL McCormack","year":"2002","unstructured":"McCormack AL, Thiruchelvam M, Manning-Bog AB, Thiffault C, Langston JW, Cory-Slechta DA, Di Monte DA (2002) Environmental risk factors and Parkinson\u2019s disease: selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat. Neurobiol Dis 10:119\u2013127","journal-title":"Neurobiol Dis"},{"key":"1788_CR128","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.nbd.2011.12.040","volume":"46","author":"K McDowell","year":"2012","unstructured":"McDowell K, Chesselet MF (2012) Animal models of the non-motor features of Parkinson\u2019s disease. Neurobiol Dis 46:597\u2013606. https:\/\/doi.org\/10.1016\/j.nbd.2011.12.040","journal-title":"Neurobiol Dis"},{"key":"1788_CR129","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S0304-3940(02)00296-3","volume":"326","author":"KS McNaught","year":"2002","unstructured":"McNaught KS, Belizaire R, Jenner P, Olanow CW, Isacson O (2002) Selective loss of 20S proteasome alpha-subunits in the substantia nigra pars compacta in Parkinson\u2019s disease. Neurosci Lett 326:155\u2013158","journal-title":"Neurosci Lett"},{"key":"1788_CR130","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1212\/WNL.66.10_suppl_4.S37","volume":"66","author":"KS McNaught","year":"2006","unstructured":"McNaught KS, Jackson T, JnoBaptiste R, Kapustin A, Olanow CW (2006) Proteasomal dysfunction in sporadic Parkinson\u2019s disease. Neurology 66:S37\u2013S49","journal-title":"Neurology"},{"key":"1788_CR131","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/35086067","volume":"2","author":"KS McNaught","year":"2001","unstructured":"McNaught KS, Olanow CW, Halliwell B, Isacson O, Jenner P (2001) Failure of the ubiquitin-proteasome system in Parkinson\u2019s disease. Nat Rev Neurosci 2:589\u2013594. https:\/\/doi.org\/10.1038\/35086067","journal-title":"Nat Rev Neurosci"},{"key":"1788_CR132","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/ana.20186","volume":"56","author":"KS McNaught","year":"2004","unstructured":"McNaught KS, Perl DP, Brownell AL, Olanow CW (2004) Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson\u2019s disease. Ann Neurol 56:149\u2013162. https:\/\/doi.org\/10.1002\/ana.20186","journal-title":"Ann Neurol"},{"key":"1788_CR133","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.molmed.2012.12.005","volume":"19","author":"G Mercado","year":"2013","unstructured":"Mercado G, Valdes P, Hetz C (2013) An ERcentric view of Parkinson\u2019s disease. Trends Mol Med 19:165\u2013175. https:\/\/doi.org\/10.1016\/j.molmed.2012.12.005","journal-title":"Trends Mol Med"},{"key":"1788_CR134","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3233\/JPD-2011-11023","volume":"1","author":"GE Meredith","year":"2011","unstructured":"Meredith GE, Rademacher DJ (2011) MPTP mouse models of Parkinson\u2019s disease: an update. J Parkinsons Dis 1:19\u201333. https:\/\/doi.org\/10.3233\/JPD-2011-11023","journal-title":"J Parkinsons Dis"},{"key":"1788_CR135","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/toxsci\/kfm223","volume":"100","author":"GW Miller","year":"2007","unstructured":"Miller GW (2007) Paraquat: the red herring of Parkinson\u2019s disease research. Toxicol Sci 100:1\u20132. https:\/\/doi.org\/10.1093\/toxsci\/kfm223","journal-title":"Toxicol Sci"},{"key":"1788_CR136","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1016\/0006-291X(89)91141-8","volume":"163","author":"Y Mizuno","year":"1989","unstructured":"Mizuno Y, Ohta S, Tanaka M, Takamiya S, Suzuki K, Sato T, Oya H, Ozawa T, Kagawa Y (1989) Deficiencies in complex I subunits of the respiratory chain in Parkinson\u2019s disease. Biochem Biophys Res Commun 163:1450\u20131455","journal-title":"Biochem Biophys Res Commun"},{"key":"1788_CR137","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.neuropharm.2013.10.009","volume":"77","author":"N Moisoi","year":"2014","unstructured":"Moisoi N, Fedele V, Edwards J, Martins LM (2014) Loss of PINK1 enhances neurodegeneration in a mouse model of Parkinson\u2019s disease triggered by mitochondrial stress. Neuropharmacology 77:350\u2013357. https:\/\/doi.org\/10.1016\/j.neuropharm.2013.10.009","journal-title":"Neuropharmacology"},{"key":"1788_CR138","doi-asserted-by":"publisher","first-page":"103","DOI":"10.5607\/en.2015.24.2.103","volume":"24","author":"HE Moon","year":"2015","unstructured":"Moon HE, Paek SH (2015) Mitochondrial dysfunction in Parkinson\u2019s disease. Exp Neurobiol 24:103\u2013116. https:\/\/doi.org\/10.5607\/en.2015.24.2.103","journal-title":"Exp Neurobiol"},{"key":"1788_CR139","doi-asserted-by":"publisher","first-page":"6609","DOI":"10.1038\/ncomms7609","volume":"6","author":"O Moscovitz","year":"2015","unstructured":"Moscovitz O, Ben-Nissan G, Fainer I, Pollack D, Mizrachi L, Sharon M (2015) The Parkinson\u2019s-associated protein DJ-1 regulates the 20S proteasome. Nat Commun 6:6609. https:\/\/doi.org\/10.1038\/ncomms7609","journal-title":"Nat Commun"},{"key":"1788_CR140","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1038\/ng.3043","volume":"46","author":"MA Nalls","year":"2014","unstructured":"Nalls MA, Pankratz N, Lill CM, Do CB, Hernandez DG, Saad M, DeStefano AL, Kara E, Bras J, Sharma M, Schulte C, Keller MF, Arepalli S, Letson C, Edsall C, Stefansson H, Liu X, Pliner H, Lee JH, Cheng R, Ikram MA, Ioannidis JP, Hadjigeorgiou GM, Bis JC, Martinez M, Perlmutter JS, Goate A, Marder K, Fiske B, Sutherland M, Xiromerisiou G, Myers RH, Clark LN, Stefansson K, Hardy JA, Heutink P, Chen H, Wood NW, Houlden H, Payami H, Brice A, Scott WK, Gasser T, Bertram L, Eriksson N, Foroud T, Singleton AB (2014) Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson\u2019s disease. Nat Genet 46:989\u2013993. https:\/\/doi.org\/10.1038\/ng.3043","journal-title":"Nat Genet"},{"key":"1788_CR141","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1083\/jcb.200809125","volume":"183","author":"D Narendra","year":"2008","unstructured":"Narendra D, Tanaka A, Suen DF, Youle RJ (2008) Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J Cell Biol 183:795\u2013803. https:\/\/doi.org\/10.1083\/jcb.200809125","journal-title":"J Cell Biol"},{"key":"1788_CR142","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.nbd.2014.09.012","volume":"73","author":"U Nordstrom","year":"2015","unstructured":"Nordstrom U, Beauvais G, Ghosh A, Pulikkaparambil Sasidharan BC, Lundblad M, Fuchs J, Joshi RL, Lipton JW, Roholt A, Medicetty S, Feinstein TN, Steiner JA, Escobar Galvis ML, Prochiantz A, Brundin P (2015) Progressive nigrostriatal terminal dysfunction and degeneration in the engrailed1 heterozygous mouse model of Parkinson\u2019s disease. Neurobiol Dis 73:70\u201382. https:\/\/doi.org\/10.1016\/j.nbd.2014.09.012","journal-title":"Neurobiol Dis"},{"key":"1788_CR143","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1056\/NEJM2003ra020003","volume":"348","author":"RL Nussbaum","year":"2003","unstructured":"Nussbaum RL, Ellis CE (2003) Alzheimer\u2019s disease and Parkinson\u2019s disease. New Engl J Med 348:1356\u20131364. https:\/\/doi.org\/10.1056\/NEJM2003ra020003","journal-title":"New Engl J Med"},{"key":"1788_CR144","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1002\/mds.27115","volume":"32","author":"JA Obeso","year":"2017","unstructured":"Obeso JA, Stamelou M, Goetz CG, Poewe W, Lang AE, Weintraub D, Burn D, Halliday GM, Bezard E, Przedborski S, Lehericy S, Brooks DJ, Rothwell JC, Hallett M, DeLong MR, Marras C, Tanner CM, Ross GW, Langston JW, Klein C, Bonifati V, Jankovic J, Lozano AM, Deuschl G, Bergman H, Tolosa E, Rodriguez-Violante M, Fahn S, Postuma RB, Berg D, Marek K, Standaert DG, Surmeier DJ, Olanow CW, Kordower JH, Calabresi P, Schapira AHV, Stoessl AJ (2017) Past, present, and future of Parkinson\u2019s disease: a special essay on the 200th anniversary of the Shaking Palsy. Mov Disord 32:1264\u20131310. https:\/\/doi.org\/10.1002\/mds.27115","journal-title":"Mov Disord"},{"key":"1788_CR145","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.cmet.2013.04.014","volume":"17","author":"LD Osellame","year":"2013","unstructured":"Osellame LD, Rahim AA, Hargreaves IP, Gegg ME, Richard-Londt A, Brandner S, Waddington SN, Schapira AH, Duchen MR (2013) Mitochondria and quality control defects in a mouse model of Gaucher disease\u2013links to Parkinson\u2019s disease. Cell Metab 17:941\u2013953. https:\/\/doi.org\/10.1016\/j.cmet.2013.04.014","journal-title":"Cell Metab"},{"key":"1788_CR146","doi-asserted-by":"publisher","first-page":"e54711","DOI":"10.1371\/journal.pone.0054711","volume":"8","author":"SM Paine","year":"2013","unstructured":"Paine SM, Anderson G, Bedford K, Lawler K, Mayer RJ, Lowe J, Bedford L (2013) Pale body-like inclusion formation and neurodegeneration following depletion of 26S proteasomes in mouse brain neurones are independent of alpha-synuclein. PLoS One 8:e54711. https:\/\/doi.org\/10.1371\/journal.pone.0054711","journal-title":"PLoS One"},{"key":"1788_CR147","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/0005-2728(94)00202-G","volume":"1229","author":"CM Palmeira","year":"1995","unstructured":"Palmeira CM, Moreno AJ, Madeira VMC (1995) Mitochondrial bioenergetics is affected by the herbicide paraquat. Bba Bioenergetics 1229:187\u2013192. https:\/\/doi.org\/10.1016\/0005-2728(94)00202-G","journal-title":"Bba Bioenergetics"},{"key":"1788_CR148","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.phrs.2016.04.004","volume":"110","author":"C Palomo-Garo","year":"2016","unstructured":"Palomo-Garo C, Gomez-Galvez Y, Garcia C, Fernandez-Ruiz J (2016) Targeting the cannabinoid CB2 receptor to attenuate the progression of motor deficits in LRRK2-transgenic mice. Pharmacol Res 110:181\u2013192. https:\/\/doi.org\/10.1016\/j.phrs.2016.04.004","journal-title":"Pharmacol Res"},{"key":"1788_CR149","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1093\/brain\/awm318","volume":"131","author":"TH Pan","year":"2008","unstructured":"Pan TH, Kondo S, Le WD, Jankovic J (2008) The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson\u2019s disease. Brain 131:1969\u20131978. https:\/\/doi.org\/10.1093\/brain\/awm318","journal-title":"Brain"},{"key":"1788_CR150","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1002\/mds.26243","volume":"30","author":"JS Park","year":"2015","unstructured":"Park JS, Blair NF, Sue CM (2015) The role of ATP13A2 in Parkinson\u2019s disease: clinical phenotypes and molecular mechanisms. Mov Disord 30:770\u2013779. https:\/\/doi.org\/10.1002\/mds.26243","journal-title":"Mov Disord"},{"key":"1788_CR151","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1002\/ana.410260606","volume":"26","author":"WD Parker Jr","year":"1989","unstructured":"Parker WD Jr, Boyson SJ, Parks JK (1989) Abnormalities of the electron transport chain in idiopathic Parkinson\u2019s disease. Ann Neurol 26:719\u2013723. https:\/\/doi.org\/10.1002\/ana.410260606","journal-title":"Ann Neurol"},{"key":"1788_CR152","doi-asserted-by":"publisher","first-page":"e115789","DOI":"10.1371\/journal.pone.0115789","volume":"9","author":"VL Patterson","year":"2014","unstructured":"Patterson VL, Zullo AJ, Koenig C, Stoessel S, Jo H, Liu X, Han J, Choi M, DeWan AT, Thomas JL, Kuan CY, Hoh J (2014) Neural-specific deletion of Htra2 causes cerebellar neurodegeneration and defective processing of mitochondrial OPA1. PLoS One 9:e115789. https:\/\/doi.org\/10.1371\/journal.pone.0115789","journal-title":"PLoS One"},{"key":"1788_CR153","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.1073\/pnas.0409598102","volume":"102","author":"FA Perez","year":"2005","unstructured":"Perez FA, Palmiter RD (2005) Parkin-deficient mice are not a robust model of parkinsonism. Proc Natl Acad Sci USA 102:2174\u20132179. https:\/\/doi.org\/10.1073\/pnas.0409598102","journal-title":"Proc Natl Acad Sci USA"},{"key":"1788_CR154","doi-asserted-by":"publisher","first-page":"a009332","DOI":"10.1101\/cshperspect.a009332","volume":"2","author":"C Perier","year":"2012","unstructured":"Perier C, Vila M (2012) Mitochondrial biology and Parkinson\u2019s disease. Cold Spring Harb Perspect Med 2:a009332. https:\/\/doi.org\/10.1101\/cshperspect.a009332","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"Suppl 1","key":"1788_CR155","doi-asserted-by":"publisher","first-page":"S119","DOI":"10.1016\/j.parkreldis.2015.09.004","volume":"22","author":"RF Pfeiffer","year":"2016","unstructured":"Pfeiffer RF (2016) Non-motor symptoms in Parkinson\u2019s disease. Parkinsonism Relat Disord 22(Suppl 1):S119\u2013S122. https:\/\/doi.org\/10.1016\/j.parkreldis.2015.09.004","journal-title":"Parkinsonism Relat Disord"},{"key":"1788_CR156","doi-asserted-by":"publisher","first-page":"17649","DOI":"10.1523\/JNEUROSCI.4871-11.2011","volume":"31","author":"AM Pickrell","year":"2011","unstructured":"Pickrell AM, Pinto M, Hida A, Moraes CT (2011) Striatal dysfunctions associated with mitochondrial DNA damage in dopaminergic neurons in a mouse model of Parkinson\u2019s disease. J Neurosci 31:17649\u201317658. https:\/\/doi.org\/10.1523\/JNEUROSCI.4871-11.2011","journal-title":"J Neurosci"},{"key":"1788_CR157","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1097\/00005072-199305000-00001","volume":"52","author":"MS Pollanen","year":"1993","unstructured":"Pollanen MS, Dickson DW, Bergeron C (1993) Pathology and biology of the Lewy body. J Neuropathol Exp Neurol 52:183\u2013191","journal-title":"J Neuropathol Exp Neurol"},{"key":"1788_CR158","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","volume":"276","author":"MH Polymeropoulos","year":"1997","unstructured":"Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, Pike B, Root H, Rubenstein J, Boyer R, Stenroos ES, Chandrasekharappa S, Athanassiadou A, Papapetropoulos T, Johnson WG, Lazzarini AM, Duvoisin RC, Di Iorio G, Golbe LI, Nussbaum RL (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson\u2019s disease. Science 276:2045\u20132047","journal-title":"Science"},{"key":"1788_CR159","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1002\/mds.24962","volume":"27","author":"M Poulopoulos","year":"2012","unstructured":"Poulopoulos M, Levy OA, Alcalay RN (2012) The neuropathology of genetic Parkinson\u2019s disease. Mov Disord 27:831\u2013842. https:\/\/doi.org\/10.1002\/mds.24962","journal-title":"Mov Disord"},{"key":"1788_CR160","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/0306-4522(95)00066-R","volume":"67","author":"S Przedborski","year":"1995","unstructured":"Przedborski S, Levivier M, Jiang H, Ferreira M, Jackson-Lewis V, Donaldson D, Togasaki DM (1995) Dose-dependent lesions of the dopaminergic nigrostriatal pathway induced by intrastriatal injection of 6-hydroxydopamine. Neuroscience 67:631\u2013647","journal-title":"Neuroscience"},{"key":"1788_CR161","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1093\/brain\/aww261","volume":"140","author":"A Puschmann","year":"2017","unstructured":"Puschmann A, Fiesel FC, Caulfield TR, Hudec R, Ando M, Truban D, Hou X, Ogaki K, Heckman MG, James ED, Swanberg M, Jimenez-Ferrer I, Hansson O, Opala G, Siuda J, Boczarska-Jedynak M, Friedman A, Koziorowski D, Aasly JO, Lynch T, Mellick GD, Mohan M, Silburn PA, Sanotsky Y, Vilarino-Guell C, Farrer MJ, Chen L, Dawson VL, Dawson TM, Wszolek ZK, Ross OA, Springer W (2017) Heterozygous PINK1 p. G411S increases risk of Parkinson\u2019s disease via a dominant-negative mechanism. Brain 140:98\u2013117. https:\/\/doi.org\/10.1093\/brain\/aww261","journal-title":"Brain"},{"key":"1788_CR162","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1756-6606-1-17","volume":"1","author":"L Qiao","year":"2008","unstructured":"Qiao L, Hamamichi S, Caldwell KA, Caldwell GA, Yacoubian TA, Wilson S, Xie ZL, Speake LD, Parks R, Crabtree D, Liang Q, Crimmins S, Schneider L, Uchiyama Y, Iwatsubo T, Zhou Y, Peng L, Lu Y, Standaert DG, Walls KC, Shacka JJ, Roth KA, Zhang J (2008) Lysosomal enzyme cathepsin D protects against alpha-synuclein aggregation and toxicity. Mol Brain 1:17. https:\/\/doi.org\/10.1186\/1756-6606-1-17","journal-title":"Mol Brain"},{"key":"1788_CR163","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1038\/ng1884","volume":"38","author":"A Ramirez","year":"2006","unstructured":"Ramirez A, Heimbach A, Grundemann J, Stiller B, Hampshire D, Cid LP, Goebel I, Mubaidin AF, Wriekat AL, Roeper J, Al-Din A, Hillmer AM, Karsak M, Liss B, Woods CG, Behrens MI, Kubisch C (2006) Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase. Nat Genet 38:1184\u20131191. https:\/\/doi.org\/10.1038\/ng1884","journal-title":"Nat Genet"},{"key":"1788_CR164","doi-asserted-by":"publisher","first-page":"e18568","DOI":"10.1371\/journal.pone.0018568","volume":"6","author":"D Ramonet","year":"2011","unstructured":"Ramonet D, Daher JP, Lin BM, Stafa K, Kim J, Banerjee R, Westerlund M, Pletnikova O, Glauser L, Yang L, Liu Y, Swing DA, Beal MF, Troncoso JC, McCaffery JM, Jenkins NA, Copeland NG, Galter D, Thomas B, Lee MK, Dawson TM, Dawson VL, Moore DJ (2011) Dopaminergic neuronal loss, reduced neurite complexity and autophagic abnormalities in transgenic mice expressing G2019S mutant LRRK2. PLoS One 6:e18568. https:\/\/doi.org\/10.1371\/journal.pone.0018568","journal-title":"PLoS One"},{"key":"1788_CR165","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1093\/toxsci\/kfi304","volume":"88","author":"JR Richardson","year":"2005","unstructured":"Richardson JR, Quan Y, Sherer TB, Greenamyre JT, Miller GW (2005) Paraquat neurotoxicity is distinct from that of MPTP and rotenone. Toxicol Sci 88:193\u2013201. https:\/\/doi.org\/10.1093\/toxsci\/kfi304","journal-title":"Toxicol Sci"},{"key":"1788_CR166","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1007\/s007020200060","volume":"109","author":"G Richter","year":"2002","unstructured":"Richter G, Sonnenschein A, Grunewald T, Reichmann H, Janetzky B (2002) Novel mitochondrial DNA mutations in Parkinson\u2019s disease. J Neural Transm (Vienna) 109:721\u2013729. https:\/\/doi.org\/10.1007\/s007020200060","journal-title":"J Neural Transm (Vienna)"},{"key":"1788_CR167","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1089\/ars.2015.6307","volume":"23","author":"EM Rocha","year":"2015","unstructured":"Rocha EM, Smith GA, Park E, Cao H, Graham AR, Brown E, McLean JR, Hayes MA, Beagan J, Izen SC, Perez-Torres E, Hallett PJ, Isacson O (2015) Sustained systemic glucocerebrosidase inhibition induces brain alpha-synuclein aggregation, microglia and complement C1q activation in mice. Antioxid Redox Signal 23:550\u2013564. https:\/\/doi.org\/10.1089\/ars.2015.6307","journal-title":"Antioxid Redox Signal"},{"key":"1788_CR168","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1016\/j.neurobiolaging.2015.02.018","volume":"36","author":"M Salganik","year":"2015","unstructured":"Salganik M, Sergeyev VG, Shinde V, Meyers CA, Gorbatyuk MS, Lin JH, Zolotukhin S, Gorbatyuk OS (2015) The loss of glucose-regulated protein 78 (GRP78) during normal aging or from siRNA knockdown augments human alpha-synuclein (alpha-syn) toxicity to rat nigral neurons. Neurobiol Aging 36:2213\u20132223. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2015.02.018","journal-title":"Neurobiol Aging"},{"key":"1788_CR169","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/S0753-3322(99)80080-8","volume":"53","author":"H Salman","year":"1999","unstructured":"Salman H, Bergman M, Djaldetti R, Bessler H, Djaldetti M (1999) Decreased phagocytic function in patients with Parkinson\u2019s disease. Biomed Pharmacother 53:146\u2013148. https:\/\/doi.org\/10.1016\/S0753-3322(99)80080-8","journal-title":"Biomed Pharmacother"},{"key":"1788_CR170","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/0306-4522(94)90605-X","volume":"59","author":"H Sauer","year":"1994","unstructured":"Sauer H, Oertel WH (1994) Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat. Neuroscience 59:401\u2013415","journal-title":"Neuroscience"},{"key":"1788_CR171","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.mcn.2015.03.013","volume":"66","author":"AH Schapira","year":"2015","unstructured":"Schapira AH (2015) Glucocerebrosidase and Parkinson disease: recent advances. Mol Cell Neurosci 66:37\u201342. https:\/\/doi.org\/10.1016\/j.mcn.2015.03.013","journal-title":"Mol Cell Neurosci"},{"key":"1788_CR172","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/ana.20934","volume":"60","author":"AH Schapira","year":"2006","unstructured":"Schapira AH, Cleeter MW, Muddle JR, Workman JM, Cooper JM, King RH (2006) Proteasomal inhibition causes loss of nigral tyrosine hydroxylase neurons. Ann Neurol 60:253\u2013255. https:\/\/doi.org\/10.1002\/ana.20934","journal-title":"Ann Neurol"},{"key":"1788_CR173","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/S0140-6736(89)92366-0","volume":"1","author":"AH Schapira","year":"1989","unstructured":"Schapira AH, Cooper JM, Dexter D, Jenner P, Clark JB, Marsden CD (1989) Mitochondrial complex I deficiency in Parkinson\u2019s disease. Lancet 1:1269","journal-title":"Lancet"},{"key":"1788_CR174","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/nrn.2017.62","volume":"18","author":"AHV Schapira","year":"2017","unstructured":"Schapira AHV, Chaudhuri KR, Jenner P (2017) Non-motor features of Parkinson disease. Nat Rev Neurosci 18:435\u2013450. https:\/\/doi.org\/10.1038\/nrn.2017.62","journal-title":"Nat Rev Neurosci"},{"key":"1788_CR175","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1172\/JCI61332","volume":"122","author":"S Selvaraj","year":"2012","unstructured":"Selvaraj S, Sun Y, Watt JA, Wang S, Lei S, Birnbaumer L, Singh BB (2012) Neurotoxin-induced ER stress in mouse dopaminergic neurons involves downregulation of TRPC1 and inhibition of AKT\/mTOR signaling. J Clin Investig 122:1354\u20131367. https:\/\/doi.org\/10.1172\/JCI61332","journal-title":"J Clin Investig"},{"key":"1788_CR176","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.neuint.2006.07.015","volume":"50","author":"R Setsuie","year":"2007","unstructured":"Setsuie R, Wang YL, Mochizuki H, Osaka H, Hayakawa H, Ichihara N, Li H, Furuta A, Sano Y, Sun YJ, Kwon J, Kabuta T, Yoshimi K, Aoki S, Mizuno Y, Noda M, Wada K (2007) Dopaminergic neuronal loss in transgenic mice expressing the Parkinson\u2019s disease-associated UCH-L1 I93M mutant. Neurochem Int 50:119\u2013129. https:\/\/doi.org\/10.1016\/j.neuint.2006.07.015","journal-title":"Neurochem Int"},{"key":"1788_CR177","doi-asserted-by":"publisher","first-page":"9678","DOI":"10.1021\/bi800699v","volume":"47","author":"D Sevlever","year":"2008","unstructured":"Sevlever D, Jiang P, Yen SH (2008) Cathepsin D is the main lysosomal enzyme involved in the degradation of alpha-synuclein and generation of its carboxy-terminally truncated species. Biochemistry 47:9678\u20139687. https:\/\/doi.org\/10.1021\/bi800699v","journal-title":"Biochemistry"},{"key":"1788_CR178","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.neurobiolaging.2015.10.040","volume":"38","author":"CH Shi","year":"2016","unstructured":"Shi CH, Mao CY, Zhang SY, Yang J, Song B, Wu P, Zuo CT, Liu YT, Ji Y, Yang ZH, Wu J, Zhuang ZP, Xu YM (2016) CHCHD2 gene mutations in familial and sporadic Parkinson\u2019s disease. Neurobiol Aging 38:217. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2015.10.040 (e219\u2013213)","journal-title":"Neurobiol Aging"},{"key":"1788_CR179","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/srep00262","volume":"2","author":"DR Shimshek","year":"2012","unstructured":"Shimshek DR, Schweizer T, Schmid P, van der Putten PH (2012) Excess alpha-synuclein worsens disease in mice lacking ubiquitin carboxy-terminal hydrolase L1. Sci Rep 2:262. https:\/\/doi.org\/10.1038\/srep00262","journal-title":"Sci Rep"},{"key":"1788_CR180","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","volume":"361","author":"E Sidransky","year":"2009","unstructured":"Sidransky E, Nalls MA, Aasly JO, Aharon-Peretz J, Annesi G, Barbosa ER, Bar-Shira A, Berg D, Bras J, Brice A, Chen CM, Clark LN, Condroyer C, De Marco EV, Durr A, Eblan MJ, Fahn S, Farrer MJ, Fung HC, Gan-Or Z, Gasser T, Gershoni-Baruch R, Giladi N, Griffith A, Gurevich T, Januario C, Kropp P, Lang AE, Lee-Chen GJ, Lesage S, Marder K, Mata IF, Mirelman A, Mitsui J, Mizuta I, Nicoletti G, Oliveira C, Ottman R, Orr-Urtreger A, Pereira LV, Quattrone A, Rogaeva E, Rolfs A, Rosenbaum H, Rozenberg R, Samii A, Samaddar T, Schulte C, Sharma M, Singleton A, Spitz M, Tan EK, Tayebi N, Toda T, Troiano AR, Tsuji S, Wittstock M, Wolfsberg TG, Wu YR, Zabetian CP, Zhao Y, Ziegler SG (2009) Multicenter analysis of glucocerebrosidase mutations in Parkinson\u2019s Disease. New Engl J Med 361:1651\u20131661. https:\/\/doi.org\/10.1056\/Nejmoa0901281","journal-title":"New Engl J Med"},{"key":"1788_CR181","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1126\/science.1090278","volume":"302","author":"AB Singleton","year":"2003","unstructured":"Singleton AB, Farrer M, Johnson J, Singleton A, Hague S, Kachergus J, Hulihan M, Peuralinna T, Dutra A, Nussbaum R, Lincoln S, Crawley A, Hanson M, Maraganore D, Adler C, Cookson MR, Muenter M, Baptista M, Miller D, Blancato J, Hardy J, Gwinn-Hardy K (2003) Alpha-synuclein locus triplication causes Parkinson\u2019s disease. Science 302:841. https:\/\/doi.org\/10.1126\/science.1090278","journal-title":"Science"},{"key":"1788_CR182","first-page":"333","volume":"28","author":"H Slodzinski","year":"2009","unstructured":"Slodzinski H, Moran LB, Michael GJ, Wang B, Novoselov S, Cheetham ME, Pearce RK, Graeber MB (2009) Homocysteine-induced endoplasmic reticulum protein (herp) is up-regulated in parkinsonian substantia nigra and present in the core of Lewy bodies. Clin Neuropathol 28:333\u2013343","journal-title":"Clin Neuropathol"},{"key":"1788_CR183","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.expneurol.2012.06.035","volume":"237","author":"GA Smith","year":"2012","unstructured":"Smith GA, Isacson O, Dunnett SB (2012) The search for genetic mouse models of prodromal Parkinson\u2019s disease. Exp Neurol 237:267\u2013273. https:\/\/doi.org\/10.1016\/j.expneurol.2012.06.035","journal-title":"Exp Neurol"},{"key":"1788_CR184","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1016\/j.ajpath.2010.12.051","volume":"178","author":"JD Sokolowski","year":"2011","unstructured":"Sokolowski JD, Mandell JW (2011) Phagocytic clearance in neurodegeneration. Am J Pathol 178:1416\u20131428. https:\/\/doi.org\/10.1016\/j.ajpath.2010.12.051","journal-title":"Am J Pathol"},{"key":"1788_CR185","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.brainres.2014.11.013","volume":"1594","author":"L Song","year":"2015","unstructured":"Song L, Cortopassi G (2015) Mitochondrial complex I defects increase ubiquitin in substantia nigra. Brain Res 1594:82\u201391. https:\/\/doi.org\/10.1016\/j.brainres.2014.11.013","journal-title":"Brain Res"},{"key":"1788_CR186","doi-asserted-by":"publisher","first-page":"5147","DOI":"10.1093\/hmg\/dds365","volume":"21","author":"L Song","year":"2012","unstructured":"Song L, Shan Y, Lloyd KC, Cortopassi GA (2012) Mutant twinkle increases dopaminergic neurodegeneration, mtDNA deletions and modulates Parkin expression. Hum Mol Genet 21:5147\u20135158. https:\/\/doi.org\/10.1093\/hmg\/dds365","journal-title":"Hum Mol Genet"},{"key":"1788_CR187","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"MG Spillantini","year":"1997","unstructured":"Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M (1997) Alpha-synuclein in Lewy bodies. Nature 388:839\u2013840. https:\/\/doi.org\/10.1038\/42166","journal-title":"Nature"},{"key":"1788_CR188","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1093\/hmg\/ddi215","volume":"14","author":"KM Strauss","year":"2005","unstructured":"Strauss KM, Martins LM, Plun-Favreau H, Marx FP, Kautzmann S, Berg D, Gasser T, Wszolek Z, Muller T, Bornemann A, Wolburg H, Downward J, Riess O, Schulz JB, Kruger R (2005) Loss of function mutations in the gene encoding Omi\/HtrA2 in Parkinson\u2019s disease. Hum Mol Genet 14:2099\u20132111. https:\/\/doi.org\/10.1093\/hmg\/ddi215","journal-title":"Hum Mol Genet"},{"key":"1788_CR189","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.neuro.2006.06.006","volume":"27","author":"F Sun","year":"2006","unstructured":"Sun F, Anantharam V, Zhang D, Latchoumycandane C, Kanthasamy A, Kanthasamy AG (2006) Proteasome inhibitor MG-132 induces dopaminergic degeneration in cell culture and animal models. Neurotoxicology 27:807\u2013815. https:\/\/doi.org\/10.1016\/j.neuro.2006.06.006","journal-title":"Neurotoxicology"},{"key":"1788_CR190","doi-asserted-by":"publisher","first-page":"354","DOI":"10.3389\/fimmu.2014.00354","volume":"5","author":"Z Szondy","year":"2014","unstructured":"Szondy Z, Garabuczi E, Joos G, Tsay GJ, Sarang Z (2014) Impaired clearance of apoptotic cells in chronic inflammatory diseases: therapeutic implications. Front Immunol 5:354. https:\/\/doi.org\/10.3389\/fimmu.2014.00354","journal-title":"Front Immunol"},{"key":"1788_CR191","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.nbd.2015.07.009","volume":"82","author":"P Tagliaferro","year":"2015","unstructured":"Tagliaferro P, Kareva T, Oo TF, Yarygina O, Kholodilov N, Burke RE (2015) An early axonopathy in a hLRRK2(R1441G) transgenic model of Parkinson disease. Neurobiol Dis 82:359\u2013371. https:\/\/doi.org\/10.1016\/j.nbd.2015.07.009","journal-title":"Neurobiol Dis"},{"key":"1788_CR192","doi-asserted-by":"publisher","first-page":"124165","DOI":"10.4061\/2011\/124165","volume":"2011","author":"TN Taylor","year":"2011","unstructured":"Taylor TN, Caudle WM, Miller GW (2011) VMAT2-deficient mice display nigral and extranigral pathology and motor and nonmotor symptoms of parkinson\u2019s disease. Parkinsons Dis 2011:124165. https:\/\/doi.org\/10.4061\/2011\/124165","journal-title":"Parkinsons Dis"},{"key":"1788_CR193","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/S0006-8993(00)02496-3","volume":"873","author":"M Thiruchelvam","year":"2000","unstructured":"Thiruchelvam M, Brockel BJ, Richfield EK, Baggs RB, Cory-Slechta DA (2000) Potentiated and preferential effects of combined paraquat and maneb on nigrostriatal dopamine systems: environmental risk factors for Parkinson\u2019s disease? Brain Res 873:225\u2013234","journal-title":"Brain Res"},{"key":"1788_CR194","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1111\/j.0953-816X.2004.03139.x","volume":"19","author":"MJ Thiruchelvam","year":"2004","unstructured":"Thiruchelvam MJ, Powers JM, Cory-Slechta DA, Richfield EK (2004) Risk factors for dopaminergic neuron loss in human alpha-synuclein transgenic mice. Eur J Neurosci 19:845\u2013854","journal-title":"Eur J Neurosci"},{"key":"1788_CR195","doi-asserted-by":"publisher","first-page":"3942","DOI":"10.1523\/JNEUROSCI.4965-05.2006","volume":"26","author":"GK Tofaris","year":"2006","unstructured":"Tofaris GK, Garcia Reitbock P, Humby T, Lambourne SL, O\u2019Connell M, Ghetti B, Gossage H, Emson PC, Wilkinson LS, Goedert M, Spillantini MG (2006) Pathological changes in dopaminergic nerve cells of the substantia nigra and olfactory bulb in mice transgenic for truncated human alpha-synuclein (1\u2013120): implications for Lewy body disorders. J Neurosci 26:3942\u20133950. https:\/\/doi.org\/10.1523\/JNEUROSCI.4965-05.2006","journal-title":"J Neurosci"},{"key":"1788_CR196","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s00401-015-1526-9","volume":"131","author":"JB Toledo","year":"2016","unstructured":"Toledo JB, Gopal P, Raible K, Irwin DJ, Brettschneider J, Sedor S, Waits K, Boluda S, Grossman M, Van Deerlin VM, Lee EB, Arnold SE, Duda JE, Hurtig H, Lee VM, Adler CH, Beach TG, Trojanowski JQ (2016) Pathological alpha-synuclein distribution in subjects with coincident Alzheimer\u2019s and Lewy body pathology. Acta Neuropathol 131:393\u2013409. https:\/\/doi.org\/10.1007\/s00401-015-1526-9","journal-title":"Acta Neuropathol"},{"key":"1788_CR197","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/0014-2999(68)90164-7","volume":"5","author":"U Ungerstedt","year":"1968","unstructured":"Ungerstedt U (1968) 6-Hydroxy-dopamine induced degeneration of central monoamine neurons. Eur J Pharmacol 5:107\u2013110","journal-title":"Eur J Pharmacol"},{"key":"1788_CR198","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1126\/science.1096284","volume":"304","author":"EM Valente","year":"2004","unstructured":"Valente EM, Abou-Sleiman PM, Caputo V, Muqit MM, Harvey K, Gispert S, Ali Z, Del Turco D, Bentivoglio AR, Healy DG, Albanese A, Nussbaum R, Gonzalez-Maldonado R, Deller T, Salvi S, Cortelli P, Gilks WP, Latchman DS, Harvey RJ, Dallapiccola B, Auburger G, Wood NW (2004) Hereditary early-onset Parkinson\u2019s disease caused by mutations in PINK1. Science 304:1158\u20131160. https:\/\/doi.org\/10.1126\/science.1096284","journal-title":"Science"},{"key":"1788_CR199","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1002\/ana.20256","volume":"56","author":"EM Valente","year":"2004","unstructured":"Valente EM, Salvi S, Ialongo T, Marongiu R, Elia AE, Caputo V, Romito L, Albanese A, Dallapiccola B, Bentivoglio AR (2004) PINK1 mutations are associated with sporadic early-onset parkinsonism. Ann Neurol 56:336\u2013341. https:\/\/doi.org\/10.1002\/ana.20256","journal-title":"Ann Neurol"},{"key":"1788_CR200","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1242\/dev.00464","volume":"130","author":"P van den Munckhof","year":"2003","unstructured":"van den Munckhof P, Luk KC, Ste-Marie L, Montgomery J, Blanchet PJ, Sadikot AF, Drouin J (2003) Pitx3 is required for motor activity and for survival of a subset of midbrain dopaminergic neurons. Development 130:2535\u20132542","journal-title":"Development"},{"key":"1788_CR201","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1097\/NEN.0000000000000039","volume":"73","author":"AS Van Rompuy","year":"2014","unstructured":"Van Rompuy AS, Lobbestael E, Van der Perren A, Van den Haute C, Baekelandt V (2014) Long-term overexpression of human wild-type and T240R mutant Parkin in rat substantia nigra induces progressive dopaminergic neurodegeneration. J Neuropathol Exp Neurol 73:159\u2013174. https:\/\/doi.org\/10.1097\/NEN.0000000000000039","journal-title":"J Neuropathol Exp Neurol"},{"key":"1788_CR202","doi-asserted-by":"crossref","first-page":"1","DOI":"10.55782\/ane-2015-2012","volume":"75","author":"D Varma","year":"2015","unstructured":"Varma D, Sen D (2015) Role of the unfolded protein response in the pathogenesis of Parkinson\u2019s disease. Acta Neurobiol Exp (Wars) 75:1\u201326","journal-title":"Acta Neurobiol Exp (Wars)"},{"key":"1788_CR203","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/S1474-4422(11)70213-7","volume":"10","author":"K Vekrellis","year":"2011","unstructured":"Vekrellis K, Xilouri M, Emmanouilidou E, Rideout HJ, Stefanis L (2011) Pathological roles of alpha-synuclein in neurological disorders. Lancet Neurol 10:1015\u20131025. https:\/\/doi.org\/10.1016\/S1474-4422(11)70213-7","journal-title":"Lancet Neurol"},{"key":"1788_CR204","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2202-11-1","volume":"11","author":"AC Vernon","year":"2010","unstructured":"Vernon AC, Johansson SM, Modo MM (2010) Non-invasive evaluation of nigrostriatal neuropathology in a proteasome inhibitor rodent model of Parkinson\u2019s disease. BMC Neurosci 11:1. https:\/\/doi.org\/10.1186\/1471-2202-11-1","journal-title":"BMC Neurosci"},{"key":"1788_CR205","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s12035-014-8927-y","volume":"53","author":"LM Villeneuve","year":"2016","unstructured":"Villeneuve LM, Purnell PR, Boska MD, Fox HS (2016) Early Expression of Parkinson\u2019s disease-related mitochondrial abnormalities in PINK1 knockout rats. Mol Neurobiol 53:171\u2013186. https:\/\/doi.org\/10.1007\/s12035-014-8927-y","journal-title":"Mol Neurobiol"},{"key":"1788_CR206","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.dib.2015.11.070","volume":"6","author":"LM Villeneuve","year":"2016","unstructured":"Villeneuve LM, Purnell PR, Stauch KL, Fox HS (2016) Neonatal mitochondrial abnormalities due to PINK1 deficiency: proteomics reveals early changes relevant to Parkinsons disease. Data Brief 6:428\u2013432. https:\/\/doi.org\/10.1016\/j.dib.2015.11.070","journal-title":"Data Brief"},{"key":"1788_CR207","doi-asserted-by":"publisher","first-page":"ra88","DOI":"10.1126\/scisignal.2001232","volume":"3","author":"X Wang","year":"2010","unstructured":"Wang X, Yen J, Kaiser P, Huang L (2010) Regulation of the 26S proteasome complex during oxidative stress. Sci Signal 3:ra88. https:\/\/doi.org\/10.1126\/scisignal.2001232","journal-title":"Sci Signal"},{"key":"1788_CR208","doi-asserted-by":"publisher","first-page":"25009","DOI":"10.1074\/jbc.M300227200","volume":"278","author":"JL Webb","year":"2003","unstructured":"Webb JL, Ravikumar B, Atkins J, Skepper JN, Rubinsztein DC (2003) Alpha-synuclein is degraded by both autophagy and the proteasome. J Biol Chem 278:25009\u201325013. https:\/\/doi.org\/10.1074\/jbc.M300227200","journal-title":"J Biol Chem"},{"key":"1788_CR209","doi-asserted-by":"publisher","first-page":"e31522","DOI":"10.1371\/journal.pone.0031522","volume":"7","author":"MC Wey","year":"2012","unstructured":"Wey MC, Fernandez E, Martinez PA, Sullivan P, Goldstein DS, Strong R (2012) Neurodegeneration and motor dysfunction in mice lacking cytosolic and mitochondrial aldehyde dehydrogenases: implications for Parkinson\u2019s disease. PLoS One 7:e31522. https:\/\/doi.org\/10.1371\/journal.pone.0031522","journal-title":"PLoS One"},{"key":"1788_CR210","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1111\/j.1471-4159.2008.05827.x","volume":"108","author":"T Yasuda","year":"2009","unstructured":"Yasuda T, Nihira T, Ren YR, Cao XQ, Wada K, Setsuie R, Kabuta T, Hattori N, Mizuno Y, Mochizuki H (2009) Effects of UCH-L1 on alpha-synuclein over-expression mouse model of Parkinson\u2019s disease. J Neurochem 108:932\u2013944. https:\/\/doi.org\/10.1111\/j.1471-4159.2008.05827.x","journal-title":"J Neurochem"},{"issue":"1001","key":"1788_CR211","doi-asserted-by":"publisher","first-page":"e1007","DOI":"10.1016\/j.neurobiolaging.2011.03.022","volume":"33","author":"L Zhang","year":"2012","unstructured":"Zhang L, Le W, Xie W, Dani JA (2012) Age-related changes in dopamine signaling in Nurr1 deficient mice as a model of Parkinson\u2019s disease. Neurobiol Aging 33(1001):e1007\u2013e1016. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2011.03.022","journal-title":"Neurobiol Aging"},{"key":"1788_CR212","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1111\/j.1750-3639.2003.tb00478.x","volume":"13","author":"JH Zhu","year":"2003","unstructured":"Zhu JH, Guo FL, Shelburne J, Watkins S, Chu CT (2003) Localization of phosphorylated ERK\/MAP kinases to mitochondria and autophagosomes in Lewy body diseases. Brain Pathol 13:473\u2013481","journal-title":"Brain Pathol"},{"key":"1788_CR213","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1111\/j.1460-9568.2007.05812.x","volume":"26","author":"XR Zhu","year":"2007","unstructured":"Zhu XR, Maskri L, Herold C, Bader V, Stichel CC, Gunturkun O, Lubbert H (2007) Non-motor behavioural impairments in parkin-deficient mice. Eur J Neurosci 26:1902\u20131911. https:\/\/doi.org\/10.1111\/j.1460-9568.2007.05812.x","journal-title":"Eur J Neurosci"},{"key":"1788_CR214","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.neuron.2004.11.005","volume":"44","author":"A Zimprich","year":"2004","unstructured":"Zimprich A, Biskup S, Leitner P, Lichtner P, Farrer M, Lincoln S, Kachergus J, Hulihan M, Uitti RJ, Calne DB, Stoessl AJ, Pfeiffer RF, Patenge N, Carbajal IC, Vieregge P, Asmus F, Muller-Myhsok B, Dickson DW, Meitinger T, Strom TM, Wszolek ZK, Gasser T (2004) Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 44:601\u2013607. https:\/\/doi.org\/10.1016\/j.neuron.2004.11.005","journal-title":"Neuron"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00401-017-1788-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-017-1788-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-017-1788-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T19:38:11Z","timestamp":1719603491000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00401-017-1788-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,18]]},"references-count":214,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["1788"],"URL":"https:\/\/doi.org\/10.1007\/s00401-017-1788-5","relation":{},"ISSN":["0001-6322","1432-0533"],"issn-type":[{"value":"0001-6322","type":"print"},{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,18]]},"assertion":[{"value":"1 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}